
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3E8892653CA33C3E8800034082C8.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cbm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancer Biology &amp; Medicine">
<meta name="citation_title" content="The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families">
<meta name="citation_author" content="Li Dong">
<meta name="citation_author_institution" content="Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Hailian Zhang">
<meta name="citation_author_institution" content="The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author_institution" content="Department of Oncology, Tianjin Third Central Hospital, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China">
<meta name="citation_author" content="Huan Zhang">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Yingnan Ye">
<meta name="citation_author_institution" content="Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Yanan Cheng">
<meta name="citation_author_institution" content="Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Lijuan Li">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Lijuan Wei">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Lei Han">
<meta name="citation_author_institution" content="Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Yandong Cao">
<meta name="citation_author_institution" content="Analyses Technology Co. Ltd., Beijing 102600, China">
<meta name="citation_author" content="Shixia Li">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Xishan Hao">
<meta name="citation_author_institution" content="Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Juntian Liu">
<meta name="citation_author_institution" content="The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author_institution" content="Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_author" content="Jinpu Yu">
<meta name="citation_author_institution" content="Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China">
<meta name="citation_publication_date" content="2021 Sep 28">
<meta name="citation_volume" content="19">
<meta name="citation_issue" content="6">
<meta name="citation_firstpage" content="850">
<meta name="citation_doi" content="10.20892/j.issn.2095-3941.2021.0011">
<meta name="citation_pmid" content="34570441">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/pdf/cbm-19-850.pdf">
<meta name="description" content="Approximately 5%–10% of breast cancer (BC) patients display familial traits that are genetically inherited among the members of a family. The purpose of this study was to profile the germline mutations in 43 genes with different penetration rates ...">
<meta name="og:title" content="The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Approximately 5%–10% of breast cancer (BC) patients display familial traits that are genetically inherited among the members of a family. The purpose of this study was to profile the germline mutations in 43 genes with different penetration rates ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9257317">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.20892/j.issn.2095-3941.2021.0011"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cbm-19-850.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9257317%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9257317/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9257317/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cbm.gif" alt="Cancer Biology &amp; Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cancer Biology &amp; Medicine" title="Link to Cancer Biology &amp; Medicine" shape="default" href="http://www.cancerbiomed.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancer Biol Med</button></div>. 2021 Sep 28;19(6):850–870. doi: <a href="https://doi.org/10.20892/j.issn.2095-3941.2021.0011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.20892/j.issn.2095-3941.2021.0011</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Cancer%20Biol%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer%20Biol%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer%20Biol%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancer%20Biol%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dong%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Li Dong</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Li Dong</span></h3>
<div class="p">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dong%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Li Dong</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hailian Zhang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hailian Zhang</span></h3>
<div class="p">
<sup>2</sup>The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">
<sup>4</sup>Department of Oncology, Tianjin Third Central Hospital, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hailian Zhang</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Huan Zhang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Huan Zhang</span></h3>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huan Zhang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ye%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yingnan Ye</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yingnan Ye</span></h3>
<div class="p">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ye%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yingnan Ye</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yanan Cheng</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yanan Cheng</span></h3>
<div class="p">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanan Cheng</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Lijuan Li</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Lijuan Li</span></h3>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lijuan Li</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Lijuan Wei</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Lijuan Wei</span></h3>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lijuan Wei</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Lei Han</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Lei Han</span></h3>
<div class="p">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lei Han</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yandong Cao</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yandong Cao</span></h3>
<div class="p">
<sup>5</sup>Analyses Technology Co. Ltd., Beijing 102600, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yandong Cao</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Shixia Li</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Shixia Li</span></h3>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shixia Li</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hao%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Xishan Hao</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Xishan Hao</span></h3>
<div class="p">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hao%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xishan Hao</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Juntian Liu</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Juntian Liu</span></h3>
<div class="p">
<sup>2</sup>The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juntian Liu</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Jinpu Yu</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Jinpu Yu</span></h3>
<div class="p">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinpu Yu</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div id="aff2">
<sup>2</sup>The Second Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div id="aff3">
<sup>3</sup>Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, China</div>
<div id="aff4">
<sup>4</sup>Department of Oncology, Tianjin Third Central Hospital, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin 300170, China</div>
<div id="aff5">
<sup>5</sup>Analyses Technology Co. Ltd., Beijing 102600, China</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Correspondence to: Jinpu Yu and Juntian Liu, E-mail: <span>jyu@tmu.edu.cn</span> and <span>ljt641024@163.com</span></p>
</div>
<div class="fn" id="fn1"><p>*Li Dong and Hailian Zhang contributed equally to this work.</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Jan 5; Accepted 2021 Apr 7; Issue date 2022 Jun 15.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright: © 2022, Cancer Biology &amp; Medicine</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License (CC BY) 4.0</a>, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9257317  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34570441/" class="usa-link">34570441</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective:</h3>
<p>Approximately 5%–10% of breast cancer (BC) patients display familial traits that are genetically inherited among the members of a family. The purpose of this study was to profile the germline mutations in 43 genes with different penetration rates and their correlations with phenotypic traits in Chinese familial BC families.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods:</h3>
<p>Ion Torrent S5™-based next generation sequencing was conducted on 116 subjects from 27 Chinese familial BC families.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>Eighty-one germline mutations in 27 BC predisposition genes were identified in 82.8% (96/116) of the cases. Among these, 80.8% of the mutated genes were related to DNA damage repair. Fourteen possible disease-causing variants were identified in 13 of 27 BC families. Only 25.9% (7/27) of the BC families exhibited hereditary deficiency in <em>BRCA1/2</em> genes, while 22.2% of the BC families exhibited defects in <em>non-BRCA</em> genes. In all, 41.7% (40/96) of the mutation carriers had <em>BRCA</em> mutations, 88.5% (85/96) had <em>non-BRCA</em> mutations, and 30.2% (29/96) had both <em>BRCA</em> and <em>non-BRCA</em> mutations. The BC patients with <em>BRCA</em> mutations had a higher risk of axillary lymph node metastases than those without mutations (<em>P</em> &lt; 0.05). However, the BC patients with <em>non-BRCA</em> mutations frequently had a higher occurrence of benign breast diseases than those without mutations (<em>P</em> &lt; 0.05).</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions:</h3>
<p>In addition to <em>BRCA1/2</em>, genetic variants in <em>non-BRCA</em> DNA repair genes might play significant roles in the development of familial/hereditary BC. Therefore, profiling of multiple BC predisposition genes should be more valuable for screening potential pathogenic germline mutations in Chinese familial/hereditary BC.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Familial breast cancer, predisposition genes, DNA damage repair genes, clinical features</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>For Chinese women, breast cancer (BC) has become the most common malignant tumor and the fifth most common cause of cancer death. Approximately 5%–10% of BC patients display familial traits that are genetically inherited among the members of a family<sup><a href="#r1" class="usa-link" aria-describedby="r1">1</a></sup>, and are significantly regulated by varied genetic factors. Among these genetic factors, driver genes directly stimulate BC carcinogenesis, while predisposition genes generally increase the hereditary genetic risk of BC and are the most important causes of familial clustering in BC. However, no study focusing on the germline genetic profiling of multiple BC predisposition genes has been reported in Chinese hereditary BC families. <em>BRCA1</em> and <em>BRCA2</em> are 2 well-known high penetration BC predisposition genes in hereditary BC<sup><a href="#r2" class="usa-link" aria-describedby="r2">2</a></sup>. <em>BRCA1/2</em> mutations are characteristic of an increased lifetime risk for hereditary breast and ovarian cancer syndrome<sup><a href="#r3" class="usa-link" aria-describedby="r3">3</a></sup>. The cumulative risk of BC in women with <em>BRCA</em> mutations is as high as 80% by the age of 70<sup><a href="#r4" class="usa-link" aria-describedby="r4">4</a>,<a href="#r5" class="usa-link" aria-describedby="r5">5</a></sup>. Clinical studies have shown that patients with <em>BRCA</em> mutations have a higher incidence of early-onset BC, bilateral BC, triple-negative BC, lymph node metastasis, and ipsilateral and contralateral BC recurrence<sup><a href="#r6" class="usa-link" aria-describedby="r6">6</a>–<a href="#r9" class="usa-link" aria-describedby="r9">9</a></sup>. Patients with <em>BRCA</em>-related BC are also at high risk for other cancers, such as pancreatic cancers, gastrointestinal malignancies, and melanomas<sup><a href="#r10" class="usa-link" aria-describedby="r10">10</a></sup>. Identification of germline mutations in <em>BRCA1/2</em> will not only help to identify high risk hereditary BC patients, but will also change screening, cancer risk management, and therapeutic strategies for their family members.</p>
<p>However, only 20%–40% of familial hereditary BC are caused by <em>BRCA1/2</em> mutations<sup><a href="#r11" class="usa-link" aria-describedby="r11">11</a></sup>. There is a large percentage of familial BC not associated with <em>BRCA1/2</em> mutations. Currently, more BC predisposition genes have been identified, including genes with high penetration (<em>TP53</em>, <em>CDH1</em>, <em>PTEN</em>, and <em>STK11</em>), moderate penetration (<em>PALB2</em>, <em>CHEK2</em>, <em>ATM</em>, <em>NBN</em>, etc.), and low penetration (<em>MLH1</em>, <em>MSH2</em>, <em>MSH6</em>, <em>PMS2</em>, <em>MEN1</em>, etc.)<sup><a href="#r12" class="usa-link" aria-describedby="r12">12</a>–<a href="#r14" class="usa-link" aria-describedby="r14">14</a></sup>. Most BC predisposition genes are DNA damage repair (DDR)-related genes. DDR is an important part of the mammalian cell defense mechanism and includes 5 different but functionally interrelated pathways: base excision repair (BER), nucleotide excision repair, mismatch repair (MMR), homologous recombination repair (HR), and nonhomologous end joining<sup><a href="#r15" class="usa-link" aria-describedby="r15">15</a></sup>. DDR genes recover the DNA damage caused by various factors <em>in vivo</em> and <em>in vitro</em>, thus maximizing the stability of genetic material. The decline or lack of DDR ability can lead to genome instability and the occurrence of cancer<sup><a href="#r16" class="usa-link" aria-describedby="r16">16</a></sup>.</p>
<p>It has been reported that genomic instability caused by DDR gene deficiency is one of the most important reasons for the occurrence of BC<sup><a href="#r17" class="usa-link" aria-describedby="r17">17</a>–<a href="#r19" class="usa-link" aria-describedby="r19">19</a></sup>. Comprehensive screening of genetic variants of DDR genes would therefore help to precisely evaluate hereditary susceptibilities to BC in high risk families. Next-generation sequencing (NGS) has recently enabled massive parallel sequencing at low cost, which makes high-throughput gene testing commercially available for hereditary BC susceptibility assessment with high accuracy and high efficiency<sup><a href="#r20" class="usa-link" aria-describedby="r20">20</a></sup>.</p>
<p>In this study, a total of 116 subjects from 27 Chinese hereditary BC families were enrolled, including both BC patients and their relatives. Ion Torrent S5™-based NGS was conducted to detect multiple types of germline variants in 43 genes and compare their correlations with phenotypic traits. We found that 80.8% of the mutated genes were related to DDR. Only 25.9% of BC families exhibited hereditary deficiency in <em>BRCA1/2</em> genes, while 22.2% of the BC families exhibited defects in <em>non-BRCA</em> genes. The <em>BRCA</em> mutation patients had a higher occurrence of axillary lymph node metastases, while the <em>non-BRCA</em> mutation patients frequently had a higher occurrence of benign breast diseases than those without mutations. Genetic variants in <em>non-BRCA</em> DDR genes might therefore play significant roles in the development of Chinese familial/hereditary BC, and more extensive BC predisposition genes should be considered to evaluate hereditary BC susceptibilities in high risk families.</p></section><section id="s2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="s2a"><h3 class="pmc_sec_title">Sample collection</h3>
<p>A total of 27 hereditary BC families in China were enrolled and admitted to the Second Department of Breast Cancer of Tianjin Medical University Cancer Institute and Hospital (TMUCIH) from January 2017 to January 2019. The criterion for the collection of hereditary BC families was that the families should include ≥ 2 patients with breast and/or ovarian cancer among first- and second-degree relatives. This study was approved by the Ethics Committee of Tianjin Medical University (Approval No. Ek2018050). Written consent was obtained from all patients.</p>
<p>We selected at least 1 BC patient and 1 family member from each hereditary BC family. Finally, a total of 116 subjects from 27 families were collected, which included 45 patients (42 BC, 2 ovarian cancer, and 1 endometrial cancer) and 71 healthy family members. All subjects were Chinese. Among the 42 BC patients, 36 were initially treated at TMUCIH. Clinical characteristics for these 36 patients were collected, including the age of onset, unilateral/bilateral, primary tumor diameter size, regional lymph node status, clinical stage, tumor grade, histological type, luminal type, benign breast disease, and recurrence or metastasis. When the clinical characteristics of the 36 patients were analyzed, the data of the additional 47 BC patients with a family history of BC were also included. These 47 familial BC patients were all females and were also treated at TMUCIH. The age of the patients ranged from 26–76 years. The median age was 51 years and the average age was 50.1 years. Of them, 31.9% were younger than 45 years, 36.1% had lymph node metastasis, 17.0% were triple negative BC, 29.7% were in stage III, and 21.2% were histological grade III (details are shown in <strong><a href="#cbm-19-850-s001" class="usa-link">Supplementary Table S1</a></strong>). All 47 familial BC patients were sequenced by the same assay panel as the 27 pedigree samples.</p>
<p>This study was approved by the ethics committee of TMUCIH, and all included subjects signed informed consent forms.</p></section><section id="s2b"><h3 class="pmc_sec_title">NGS panel</h3>
<p>In this study, the 43 genes selected were as follows: <em>AKT1</em>, <em>APC</em>, <em>ATM</em>, <em>ATR</em>, <em>BAP1</em>, <em>BARD1</em>, <em>BLM</em>, <em>BRAF</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>BRIP1</em>, <em>CCND1</em>, <em>CDH1</em>, <em>CDK4</em>, <em>CHEK2</em>, <em>CYP1B1</em>, <em>EGFR</em>, <em>EPCAM</em>, <em>ERBB2</em>, <em>ERBB4</em>, <em>ERCC1</em>, <em>FANCD2</em>, <em>FANCI</em>, <em>MLH1</em>, <em>MRE11A</em>, <em>MSH2</em>, <em>MSH6</em>, <em>MUTYH</em>, <em>NBN</em>, <em>NOTCH1</em>, <em>PALB2</em>, <em>PIK3CA</em>, <em>PMS2</em>, <em>PTEN</em>, <em>RAD50</em>, <em>RAD51C</em>, <em>RAD51D</em>, <em>RET</em>, <em>SMAD4</em>, <em>STK11</em>, <em>TP53</em>, <em>XPC</em>, and <em>XRCC1</em> (<strong><a href="#tb001" class="usa-link">Table 1</a></strong>). Most of the 43 genes, such as <em>APC</em>, <em>ATM</em>, <em>ATR</em>, <em>BAP1</em>, <em>BARD1</em>, <em>BLM</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>BRIP1</em>, <em>CDH1</em>, <em>CHEK2</em>, <em>CYP1B1</em>, <em>EPCAM</em>, <em>ERCC1</em>, <em>FANCD2</em>, <em>FANCI</em>, <em>MLH1</em>, <em>MRE11A</em>, <em>MSH2</em>, <em>MSH6</em>, <em>MUTYH</em>, <em>NBN</em>, <em>PALB2</em>, <em>PMS2</em>, <em>PTEN</em>, <em>RAD50</em>, <em>RAD51C</em>, <em>RAD51D</em>, <em>STK11</em>, <em>XPC</em>, and <em>XRCC1</em> were DDR genes. The panel was composed of the whole coding sequence and splicing region (exonic boundaries ± 10 bp) of each gene. The target region size of the panel was 114 kb, and 99% of the target region was covered with 1,352 amplicons (Analyses, Beijing, China).</p>
<section class="tw xbox font-sm" id="tb001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Gene list</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1"></th>
<th valign="top" align="left" rowspan="1" colspan="1">Gene</th>
<th valign="top" align="left" rowspan="1" colspan="1">Transcript</th>
<th valign="top" align="left" rowspan="1" colspan="1">Exon number</th>
<th valign="top" align="left" rowspan="1" colspan="1">Target region bases (bp)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">1</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>AKT1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005163" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005163</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">14</td>
<td valign="top" align="left" rowspan="1" colspan="1">3,008</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">2</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>APC</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000038" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000038</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">8,683</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">3</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>ATM</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000051" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000051</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">62</td>
<td valign="top" align="left" rowspan="1" colspan="1">9,792</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>ATR</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001184" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001184</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">47</td>
<td valign="top" align="left" rowspan="1" colspan="1">8,158</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">5</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BAP1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004656" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004656</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">17</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,361</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">6</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BARD1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000465" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000465</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">11</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,445</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">7</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BLM</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000057" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000057</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">21</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,465</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">8</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRAF</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004333" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004333</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">18</td>
<td valign="top" align="left" rowspan="1" colspan="1">6,459</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">9</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">22</td>
<td valign="top" align="left" rowspan="1" colspan="1">5,813</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">10</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">26</td>
<td valign="top" align="left" rowspan="1" colspan="1">10,518</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">11</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRIP1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_032043" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_032043</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">19</td>
<td valign="top" align="left" rowspan="1" colspan="1">3,941</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">12</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CCND1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_053056" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_053056</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">5</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,238</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">13</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CDH1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004360" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004360</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,810</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">14</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CDK4</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000075" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000075</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">8</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,865</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CHEK2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001005735" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001005735</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,912</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CYP1B1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000104" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000104</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">2</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,653</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">17</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>EGFR</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005228" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005228</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">9,905</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">18</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>EPCAM</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002354" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_002354</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">9</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,036</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">19</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>ERBB2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004448" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004448</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">27</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,557</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>ERBB4</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005235" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005235</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">12,097</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">21</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>ERCC1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001983" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001983</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">10</td>
<td valign="top" align="left" rowspan="1" colspan="1">3,379</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">22</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>FANCD2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001018115" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_001018115</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">43</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,922</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">23</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>FANCI</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018193" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_018193</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">36</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,168</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">24</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MLH1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000249" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000249</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">19</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,462</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">25</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MRE11A</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005591" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005591</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">19</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,318</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">26</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MSH2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000251" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000251</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,966</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">27</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MSH6</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000179" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000179</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">10</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,184</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MUTYH</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_012222" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_012222</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,861</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">29</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>NBN</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002485" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_002485</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,426</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">30</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>NOTCH1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_017617" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_017617</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">34</td>
<td valign="top" align="left" rowspan="1" colspan="1">9,568</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">31</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>PALB2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_024675" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_024675</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">13</td>
<td valign="top" align="left" rowspan="1" colspan="1">3,692</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">32</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>PIK3CA</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006218" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_006218</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">21</td>
<td valign="top" align="left" rowspan="1" colspan="1">9,259</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">33</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>PMS2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000535" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000535</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,740</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">34</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>PTEN</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000314" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000314</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">9</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,303</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">35</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RAD50</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005732" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005732</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">25</td>
<td valign="top" align="left" rowspan="1" colspan="1">4,190</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">36</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RAD51C</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_058216" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_058216</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">9</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,226</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">37</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RAD51D</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002878" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_002878</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">10</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,088</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">38</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RET</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020975" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_020975</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">3,578</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">39</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>SMAD4</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005359" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005359</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">11</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,770</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">40</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>STK11</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000455" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000455</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">9</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,393</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">41</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>TP53</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000546" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000546</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">10</td>
<td valign="top" align="left" rowspan="1" colspan="1">1,283</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">42</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>XPC</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004628" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004628</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">3,650</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">43</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>XRCC1</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_006297" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_006297</a></td>
<td valign="top" align="left" rowspan="1" colspan="1">17</td>
<td valign="top" align="left" rowspan="1" colspan="1">2,052</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s2c"><h3 class="pmc_sec_title">NGS and data processing</h3>
<p>Genomic DNA was extracted from peripheral blood samples (2–5 mL) using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The DNA library was constructed using GO prep kits (Analyses), in which every library from different samples was marked with varied indices. The prepared libraries were sequenced by Ion S5 (TMO, Shanghai, China). Qualified reads were aligned to the human reference genome hg19 by TMAP (v.5.10). The target regions were sequenced at a depth &gt; 200 times. Germline mutations (SNV/small InDel &lt; 22 bp) were detected using TVC software (v.5.10). Then, Ensembl Variant Effect Predictor software (<a href="http://grch37.ensembl.org/info/docs/tools/vep/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://grch37.ensembl.org/info/docs/tools/vep/index.html</a>) was used for variant interpretation, such as HGVS notation, Population Allele Frequencies from GnomAD (<a href="http://gnomad.broadinstitute.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://gnomad.broadinstitute.org/</a>), 1K Genomes Project (<a href="http://www.1000genomes.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.1000genomes.org</a>), Clinical Significance States assigned by HGMD (<a href="http://www.hgmd.cf.ac.uk/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.hgmd.cf.ac.uk/</a>), ClinVar (<a href="http://www.ncbi.nlm.nih.gov/clinvar/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.ncbi.nlm.nih.gov/clinvar/</a>), BRCA Exchange (<a href="https://brcaexchange.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://brcaexchange.org/</a>), and BIC (<a href="https://research.nhgri.nih.gov/bic/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://research.nhgri.nih.gov/bic/</a>). In addition, all significant mutations, including pathogenic variants, likely pathogenic variants, and variants of uncertain significance (VUS) were confirmed by Sanger sequencing.</p></section><section id="s2d"><h3 class="pmc_sec_title">Variant classification</h3>
<p>All mutations were classified according to the American College of Medical Genetics (ACMG) professional practice and guidelines<sup><a href="#r21" class="usa-link" aria-describedby="r21">21</a></sup>. Following the principles of the ACMG, all germline mutations were classified as pathogenic (P), likely pathogenic (LP), uncertain significance (US), likely benign (LB), or benign (B). Each pathogenic criterion was weighted as very strong (PVS1: nonsense, frameshift, canonical ± 1 or 2 splice sites, initiation codon), strong (PS1–4); moderate (PM1–6), or supporting (PP1–5), and each benign criterion was weighted as stand-alone (BA1), strong (BS1–4), or supporting (BP1–6). The other mutations were classified as variants of uncertain significance (VUS).</p></section><section id="s2e"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>The correlations between genetic variants and clinicopathological characteristics of patients were determined using the Student’s <em>t</em>-test, the chi-square test, or Fisher’s precise test. <em>P</em>-values less than 0.05 were considered to be statistically significant.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3a"><h3 class="pmc_sec_title">Quality assessment of sequencing data</h3>
<p>More than 26.7 GB of sequencing data were generated from 116 clinical samples. An average of 1.0 million reads for each sample was obtained. The depth of each variant was mainly 200–1,500×, and the average depth was more than 800× (<strong><a href="#fg001" class="usa-link">Figure 1A</a></strong>). On average, 98.9% of all reads could be mapped back to the hg19 genome (<strong><a href="#fg001" class="usa-link">Figure 1B</a></strong>) and 96.0% of all reads were mapped to targeted regions (<strong><a href="#fg001" class="usa-link">Figure 1C</a></strong>). After variant calling, the allele fraction plots of all the variants demonstrated a clear bimodal distribution pattern peaking at 0.5 and 1.0, which indicated that a typical distribution pattern of germline mutations was achieved (<strong><a href="#fg001" class="usa-link">Figure 1D</a></strong>).</p>
<figure class="fig xbox font-sm" id="fg001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9257317_cbm-19-850-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe5/9257317/b11d565be009/cbm-19-850-g001.jpg" loading="lazy" height="739" width="757" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fg001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Quality assessment of the sequencing data. (A) The sequencing depth of variants. (B) Percentage of all mapped reads for samples. (C) Percentage of reads mapped to target regions for samples. (D) The distribution of allele fractions across all identified variants.</p></figcaption></figure></section><section id="s3b"><h3 class="pmc_sec_title">Identification of germline mutations</h3>
<p>We detected 37,009 variants among 43 genes in 116 subjects from 27 families. After variant filtering (<strong><a href="#fg002" class="usa-link">Figure 2</a></strong>), 81 germline mutations in 26 genes were identified in 96 subjects (<strong><a href="#fg003" class="usa-link">Figure 3A</a></strong>; more details are available in Supporting Information <strong><a href="#cbm-19-850-s001" class="usa-link">Supplementary Table S2</a></strong>). The genes with ≥ 5 mutations were <em>BRCA1</em>, <em>BRCA2</em>, <em>ATM</em>, <em>BLM</em>, <em>BRIP1</em>, <em>MSH6</em>, and <em>RAD50</em>. Of the mutated genes, 80.8% (21/26) were DDR genes (<em>ATM</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>BAP1</em>, <em>BARD1</em>, <em>BRIP1</em>, <em>BLM</em>, <em>CHEK2</em>, <em>FANCD2</em>, <em>FANCI</em>, <em>MRE11A</em>, <em>NBN</em>, <em>PALB2</em>, <em>RAD50</em>, <em>RAD51C</em>, <em>MLH1</em>, <em>MSH2</em>, <em>MSH6</em>, <em>EPCAM</em>, <em>PMS2,</em> and <em>MUTYH</em>), and 19.2% (5/26) were driver genes (<em>APC</em>, <em>CDH1</em>, <em>RET</em>, <em>STK11</em>, and <em>TP53</em>). Among these DDR genes, 71.4% (15/21) were involved in HR, 23.8% (5/21) were involved in MMR, and 4.8% (1/21) were involved in BER. Of the 81 mutations, 67.9% were found in HR genes, 19.8% in MMR genes, 2.5% in BER genes, and 9.9% in driver genes (<strong><a href="#fg003" class="usa-link">Figure 3B</a></strong>). More than 90% of the mutations occurred in DDR genes. Of these mutations, 10 (12.3%) were pathogenic or likely pathogenic (P/LP), and 71 (88.7%) were VUS. There were 7 P/LP mutations detected in <em>BRCA1/2</em> genes and 3 P/LP mutations detected in <em>non-BRCA</em> genes. Four VUS were considered high risk based on software predictions and literature reports. In this article, P/LP mutations and high risk VUS were defined as possible disease-causing mutations<sup><a href="#r22" class="usa-link" aria-describedby="r22">22</a></sup>.</p>
<figure class="fig xbox font-sm" id="fg002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9257317_cbm-19-850-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe5/9257317/2dbcf7d24392/cbm-19-850-g002.jpg" loading="lazy" height="957" width="773" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fg002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Filtering steps of mutations. *Predicted as damaging by multiple software programs or reported in cancer patients.</p></figcaption></figure><figure class="fig xbox font-sm" id="fg003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9257317_cbm-19-850-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe5/9257317/32a55aee44e5/cbm-19-850-g003.jpg" loading="lazy" height="412" width="747" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fg003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of the mutated genes. (A) Number of mutations in the mutated genes. (B) Percentage of mutations in different gene types. HR: homologous recombination repair, MMR: mismatch repair, BER: base excision repair.</p></figcaption></figure></section><section id="s3c"><h3 class="pmc_sec_title">The correlation between genetic mutations and hereditary BC families</h3>
<p>Among the 27 familial BC families, 48.1% (13/27) had possible disease-causing mutations in known BC predisposition genes, including <em>BRCA1</em>, <em>BRCA2</em>, <em>BLM</em>, <em>BRIP1</em>, <em>MSH2</em>, <em>MSH6</em>, <em>RAD51C</em>, and <em>RET</em>. The cause of hereditary BC in 51.9% (14/27) of the families was unknown. Hereditary BC in 25.9% (7/27) of the families was associated with <em>BRCA1/2</em> genes, while that in 22.2% (6/27) was associated with <em>non-BRCA</em> genes (<strong><a href="#tb002" class="usa-link">Table 2</a></strong>). This showed that testing the <em>non-BRCA</em> genes increased the detection of hereditary BC by 22.2%.</p>
<section class="tw xbox font-sm" id="tb002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>The correlation between mutation genes and cancer types of hereditary breast cancer families</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Types of cancer within a family</th>
<th valign="top" align="left" rowspan="1" colspan="1">No. of families</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA</em>-related families</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>Non-BRCA</em>-related families</th>
<th valign="top" align="left" rowspan="1" colspan="1">Families of unknown reason</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Breast cancer</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">11</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (27.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (18.2%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (54.5%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Breast cancer + ovarian cancer</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (50.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (50.0%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Breast cancer (+ ovarian cancer) other cancers</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">12</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (16.7%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (33.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (50.0%)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Total</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">27</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (25.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (22.2%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (51.9%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Of these 27 families, 11 (40.7%) were characterized by BC only, 4 (14.8%) by both BC and ovarian cancer, and 12 (44.5%) by other cancer types besides BC (and ovarian cancer), such as lung cancer, stomach cancer, esophageal cancer, colorectal cancer, and endometrial cancer (<strong><a href="#tb003" class="usa-link">Table 3</a></strong>). Of the families with BC only, 27.3% (3/11) were related with <em>BRCA</em> genes and 18.2% (2/11) were related with <em>non-BRCA</em> genes. However, of the families with cancer types other than BC (and ovarian cancer), more were related with <em>non-BRCA</em> genes than <em>BRCA</em> genes (33.3% <em>vs.</em> 16.7%) (<strong><a href="#tb002" class="usa-link">Table 2</a></strong>).</p>
<section class="tw xbox font-sm" id="tb003"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>The corresponding variants and the cancer types of each family</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Family</th>
<th valign="top" align="left" rowspan="1" colspan="1">The possible corresponding variants</th>
<th valign="top" align="left" rowspan="1" colspan="1">Cancer types of a family</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F01</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA2</em> p.Glu97Term</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F02</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BLM</em> p.Leu60Ile</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F03</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F04</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F05</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MSH2</em> p.Met688Ile</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F06</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Hepatic carcinoma</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F07</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F08</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Colorectal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F09</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA1</em> p.Glu1836fs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRIP1</em> p.Lys222Term</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F10</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA2</em> p.Ser2984Term</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Esophageal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Stomach cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F11</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F12</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer,</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Colorectal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F13</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA1</em> p.Leu1306fs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Colorectal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Non-Hodgkin’s</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">lymphoma</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Esophageal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F14</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Stomach cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Esophageal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Cervical cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Thyroid cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F15</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F16</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RAD51C</em> p.Arg370Term</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Colorectal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F17</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F18</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RET</em> p.Glu632Lys</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Esophageal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F19</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Colorectal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F20</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F22</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA1</em> p.Thr327fs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F23</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA2</em> p.Arg2520Term</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F24</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F25</td>
<td valign="top" align="left" rowspan="1" colspan="1">Uncertain</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Colorectal cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F27</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BLM</em> p.Asp1116fs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Stomach cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Lung cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F28</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA1</em> p.Asp1362fs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Ovarian cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">F29</td>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MSH6</em> p.Arg841fs</td>
<td valign="top" align="left" rowspan="1" colspan="1">Breast cancer</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">Endometrial cancer</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="s3d"><h3 class="pmc_sec_title">The distribution of possible disease-causing mutations in BRCA1/2 genes</h3>
<p>Among the mutation carriers, 24.0% (23/96) carried possible disease-causing mutations in <em>BRCA</em> genes. Of them, 47.8% (11/23) were carriers of the <em>BRCA1</em> gene, and 52.2% (12/23) were carriers of the <em>BRCA2</em> gene. Therefore, mutation carriers of the <em>BRCA2</em> gene occurred 1.09 times more frequently than those of the <em>BRCA1</em> gene in these 27 Chinese hereditary BC families.</p>
<p>Four possible disease-causing mutations in the <em>BRCA1</em> gene were found in 27 familial BC families. There were 3 mutations located in exon 10 and 1 located in exon 23 (<strong><a href="#fg004" class="usa-link">Figure 4A</a></strong>). <em>BRCA1</em> p.Glu1836fs was located in the BRCT2 domain of BRCA1. The BRCT domain is found in a large variety of proteins involved in DNA repair, recombination, and cell cycle control, and functions as a protein-protein interaction module<sup><a href="#r23" class="usa-link" aria-describedby="r23">23</a>,<a href="#r24" class="usa-link" aria-describedby="r24">24</a></sup>. <em>BRCA1</em> p.Thr327fs was located upstream of the serine-rich domain associated with BRCT and found in a family with 2 BC patients, 1 of whom was diagnosed with BC at 32 years of age and died of BC. The healthy member with this mutation is taking tamoxifen orally to prevent BC under the guidance of her physician. <em>BRCA1</em> p.Asp1362fs and p.Leu1306fs were not located in the functional domain of BRCA1. Both were found in a family with BC and ovarian cancer. Four possible disease-causing mutations in the <em>BRCA1</em> gene previously found in 146 sporadic BC patients were located in exons 4, 10, 23, and all in the functional domain<sup><a href="#r22" class="usa-link" aria-describedby="r22">22</a></sup>. There was no significant difference in the location of these mutations in the <em>BRCA1</em> gene between pedigrees and sporadic patients. Of the 8 possible disease-causing mutations in the <em>BRCA1</em> gene, 7 (87.5%) were frameshift mutations, and 5 (62.5%) were located in the functional domain of the <em>BRCA1</em> gene, especially BRCT2 (<strong><a href="#fg004" class="usa-link">Figure 4A</a></strong>). The patients with <em>BRCA1</em> p.Ile1824fs and p.Leu1306fs were diagnosed with BC at the age of ≤ 45 years and had lymph node metastases. The tumor-node-metastasis (TNM) stage of <em>BRCA1</em> p.Ile1824fs mutation carriers was stage III. The patient with <em>BRCA1</em> p.Leu481fs was diagnosed with BC at the age of &gt; 45 years but had lymph node metastasis and was in stage III. The <em>BRCA1</em> p.Asp1362fs mutation carriers were ≥ 45 years of age, in stage I, and had no lymph node metastasis.</p>
<figure class="fig xbox font-sm" id="fg004"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9257317_cbm-19-850-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe5/9257317/6313c7fe6c83/cbm-19-850-g004.jpg" loading="lazy" height="1017" width="792" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fg004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The distribution of <em>BRCA1/2</em> mutations in databases (HGMD, ClinVar, and Gnomad) and the disease-causing mutations in <em>BRCA1/2</em> genes and its effects on the BRCA protein. (A) The disease-causing mutations in the <em>BRCA1</em> gene. (B) The disease-causing mutations in the <em>BRCA2</em> gene.</p></figcaption></figure><p>Three possible disease-causing mutations in the <em>BRCA2</em> gene were found in 27 familial BC families and located in exons 3, 15, and 23 (<strong><a href="#fg004" class="usa-link">Figure 4B</a></strong>). <em>BRCA2</em> p.Arg2520Term was located in the helical domain of BRCA2. The region interacts with the DSS1 (deleted in split hand/split foot) protein in mammalian cells, which is required for normal cell growth<sup><a href="#r25" class="usa-link" aria-describedby="r25">25</a></sup>. <em>BRCA2</em> p.Glu97Term and p.Ser2984Term were not located in the functional domain of BRCA2. <em>BRCA2</em> p.Glu97Term was found in a family with 2 BC patients. The onset age of the patients was over 50 years. <em>BRCA2</em> p.Ser2984Term was found in a family with 3 BC patients. Among them, 1 patient developed BC at the age of 35 years, and 1 patient experienced contralateral BC after she was diagnosed with BC at 42 years of age. Six possible disease-causing mutations in the <em>BRCA2</em> gene found previously in 146 sporadic BC patients were located in exons 3, 11, 19, and 23. The distribution of possible disease-causing mutations found in sporadic patients may be more dispersed in the <em>BRCA2</em> gene<sup><a href="#r22" class="usa-link" aria-describedby="r22">22</a></sup>. Of the 9 possible disease-causing mutations of the BRCA2 gene, 6 (66.7%) were nonsense mutations, and mutations within exon 11 of <em>BRCA2</em> were the most common. We found that most of the mutations carried by patients with an onset age of ≤ 45 years were located in the region of exon 15 or behind exon 15, and 80.0% of the patients with <em>BRCA2</em> possible disease-causing mutations had lymph node metastases. The patients with <em>BRCA2</em> p.Glu38Lys, p.Val2050fs, p.Arg2520Term, p.Ser2984Term, and p.Trp2990Term were diagnosed with BC at the age of ≤ 45 years and had lymph node metastases. The TNM stage of <em>BRCA2</em> p.Glu38Lys, p.Val2050fs, and p.Trp2990Term mutation carriers was stage III. The <em>BRCA2</em> p.Ser1404Term mutation carriers were more than 45 years of age, were in stage I, and had no lymph node metastasis.</p></section><section id="s3e"><h3 class="pmc_sec_title">Possible disease-causing mutations in non-BRCA genes</h3>
<p>Seven possible disease-causing mutations in <em>non-BRCA</em> genes were found in 27 familial BC families including 3 likely pathogenic mutations in the <em>BLM</em>, <em>BRIP1</em>, and <em>MSH6</em> genes, and 4 high risk VUSs in the <em>BLM</em>, <em>MSH2</em>, <em>RAD50C</em>, and <em>RET</em> genes. <em>BLM</em> p.Asp1116fs was not present in population databases such as ExAC, gnomAD, and 1,000 Genomes. This sequence change duplicated 1 nucleotide from exon 17 of the BLM mRNA (c.3349dupA), causing a frameshift variant at codon 1,116. Loss-of-function variants in the <em>BLM</em> gene are known to be the pathogenic mechanism for Bloom syndrome<sup><a href="#r26" class="usa-link" aria-describedby="r26">26</a></sup>. The sequence change of <em>BRIP1</em> p.Lys222Term replaced A with T from exon 7 of the BRIP1 mRNA (c.664A&gt;T), causing a nonsense mutation at codon 222. It was also not present in population databases such as ExAC, gnomAD, and 1,000 Genomes and was recorded as pathogenic in the ClinVar database (SCV001187697). <em>MSH6</em> p.Arg841fs was not present in population databases such as ExAC, gnomAD, and 1,000 Genomes. This sequence change deleted 1 nucleotide from exon 4 of the MSH6 mRNA (c.2522delG), causing frameshift variants at codon 841. Loss-of-function variants in the <em>MSH6</em> gene are known to be the pathogenic mechanism for Lynch syndrome<sup><a href="#r27" class="usa-link" aria-describedby="r27">27</a>,<a href="#r28" class="usa-link" aria-describedby="r28">28</a></sup>. According to the guidelines of the ACMG, these 3 mutations were classified as likely pathogenic.</p>
<p>Four VUS were considered high risk in this study, namely, <em>BLM</em> p.Leu60Ile, <em>MSH2</em> p.Met688Ile, <em>RAD50C</em> p.Arg370Term, and <em>RET</em> p.Glu632Lys. <em>BLM</em> p.Leu60Ile, <em>MSH2</em> p.Met688Ile, and <em>RET</em> p.Glu632Lys were predicted to be damaging by multiple software programs. <em>BLM</em> p.Leu60Ile was recorded as having conflicting interpretations of pathogenicity in the ClinVar database without clinical information. <em>MSH2</em> p.Met688Ile was recorded with uncertain significance in the ClinVar database and reported in colorectal cancer, endometrial cancer, and Lynch syndrome<sup><a href="#r29" class="usa-link" aria-describedby="r29">29</a>–<a href="#r32" class="usa-link" aria-describedby="r32">32</a></sup>. <em>RET</em> p.Glu632Lys was recorded with uncertain significance in the ClinVar database and reported in medullary thyroid carcinoma<sup><a href="#r33" class="usa-link" aria-describedby="r33">33</a>,<a href="#r34" class="usa-link" aria-describedby="r34">34</a></sup>, Hirschsprung’s disease<sup><a href="#r35" class="usa-link" aria-describedby="r35">35</a></sup>, esophageal cancer<sup><a href="#r36" class="usa-link" aria-describedby="r36">36</a></sup>, colorectal cancer<sup><a href="#r37" class="usa-link" aria-describedby="r37">37</a></sup> and sporadic pheochromocytoma<sup><a href="#r38" class="usa-link" aria-describedby="r38">38</a></sup>. The nonsense mutation <em>RAD50C</em> p.Arg370Term exhibited the termination codon at 370 amino acids. It was not clear whether <em>RAD50C</em> p.Arg370Term would lead to nonsense mutation-mediated mRNA decay because it was located in the last exon. It was also recorded with uncertain significance in the ClinVar database. Overall, the studies have shown that deletion of the terminal 11 amino acid residues led to cell localization errors of the RAD51C protein<sup><a href="#r39" class="usa-link" aria-describedby="r39">39</a></sup>.</p></section><section id="s3f"><h3 class="pmc_sec_title">Comutation of BRCA and non-BRCA genes in the BC pedigree</h3>
<p>In this study, 82.76% (96/116) of all subjects were found to carry at least 1 gene mutation. Only 34.4% (33/96) of the mutation carriers had 1 mutation, while 65.6% (63/96) had ≥ 2 mutations simultaneously. It is common that 1 person carries &gt; 1 mutation, which was detected either in <em>BRCA1/2</em> genes or <em>non-BRCA</em> genes (<strong><a href="#fg005" class="usa-link">Figure 5</a></strong>). Twenty-nine (25.0%, 29/116) subjects carried both <em>BRCA</em> and <em>non-BRCA</em> mutations, namely, 12 patients and 17 healthy members. These non-BRCA mutations occurred in the <em>ATM</em>, <em>BAP1</em>, <em>BLM</em>, <em>BRIP1</em>, <em>CHEK2</em>, <em>EPCAM</em>, <em>MLH1</em>, <em>MSH2</em>, <em>MSH6</em>, <em>MUTYH</em>, <em>PMS2</em>, <em>RAD50</em>, <em>RAD51C</em>, and <em>TP53</em> genes, 92.9% of which were related to DDR genes. Among the comutation samples of <em>BRCA</em> and <em>non-BRCA</em> genes, there were 19 carriers with possible disease-causing mutations in <em>BRCA</em> genes and 5 carriers with possible disease-causing mutations in <em>non-BRCA</em> genes. Two carriers had possible disease-causing mutations in both <em>BRCA</em> genes and <em>non-BRCA</em> genes. Both were from 1 family with 1 BC patient and 1 ovarian cancer patient.</p>
<figure class="fig xbox font-sm" id="fg005"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9257317_cbm-19-850-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe5/9257317/2cdef9743d65/cbm-19-850-g005.jpg" loading="lazy" height="462" width="744" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fg005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The distribution of mutations and clinical features across all subjects.</p></figcaption></figure></section><section id="s3g"><h3 class="pmc_sec_title">The clinicopathological characteristics of hereditary BC patients with varied genetic mutations</h3>
<p>According to the mutation status (P, LP, VUS), 36 BC patients were divided into 3 groups: the <em>BRCA</em> mutation group (<em>n</em> = 9), <em>non-BRCA</em> mutation group (<em>n</em> = 20), and nonmutation group (<em>n</em> = 7) (<strong><a href="#tb004" class="usa-link">Table 4</a></strong>). The <em>BRCA</em> mutation group had a comparably higher risk of axillary lymph node metastasis than the nonmutation group (77.8% <em>vs.</em> 28.6%, <em>P</em> = 0.049). There was no significant difference in age, unilateral or bilateral, tumor size, TNM stage, tumor grade, histological type, luminal type, history of benign breast diseases, recurrence, or metastasis between the <em>BRCA</em> mutation group and the nonmutation group. In contrast, the <em>non-BRCA</em> mutation group had a significantly higher occurrence of benign breast disease before BC than the nonmutation group (70.0% <em>vs.</em> 14.3%, <em>P</em> = 0.021). However, there was no significant difference in other parameters.</p>
<section class="tw xbox font-sm" id="tb004"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Clinicopathological characteristics among 36 patients with different mutation status</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Features</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>n</em>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">BRCA+ (<em>n</em> = 9, %)</th>
<th valign="top" align="left" rowspan="1" colspan="1">non-BRCA+ (<em>n</em> = 20, %)</th>
<th valign="top" align="left" rowspan="1" colspan="1">Negative (<em>n</em> = 7, %)</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>P1-value</em>*</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>P2-</em>value*</th>
</tr></thead>
<tbody>
<tr><td colspan="7" valign="top" align="left" rowspan="1">
<strong>Age of onset (years)</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Mean ± size</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">44.8 ± 9.5</td>
<td valign="top" align="left" rowspan="1" colspan="1">55.7 ± 10.3</td>
<td valign="top" align="left" rowspan="1" colspan="1">51.3 ± 6.8</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.148<sup>a</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.307<sup>a</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> ≤ 45</td>
<td valign="top" align="left" rowspan="1" colspan="1">8</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (55.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (5.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.358</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.156</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> &gt; 45</td>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (44.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">19 (95.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (71.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Unilateral/bilateral</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.088</td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Unilateral</td>
<td valign="top" align="left" rowspan="1" colspan="1">31</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (55.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">19 (95.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (100.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Bilateral</td>
<td valign="top" align="left" rowspan="1" colspan="1">5</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (44.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (5.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Tumor size</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.550</td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> ≤ 3 cm</td>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (88.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">15 (75.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (71.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> &gt; 3 cm</td>
<td valign="top" align="left" rowspan="1" colspan="1">8</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (11.1%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (25.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Axillary lymph node metastasis</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.049</td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Yes</td>
<td valign="top" align="left" rowspan="1" colspan="1">16</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (77.8%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (35.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> No</td>
<td valign="top" align="left" rowspan="1" colspan="1">20</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (22.2%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">13 (65.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (71.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>TNM stage</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.263<sup>b</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.435<sup>b</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> 0 + I</td>
<td valign="top" align="left" rowspan="1" colspan="1">17</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (22.2%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (50.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (71.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> II</td>
<td valign="top" align="left" rowspan="1" colspan="1">14</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (77.8%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (30.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (14.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> III</td>
<td valign="top" align="left" rowspan="1" colspan="1">5</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (14.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Tumor grade</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.109<sup>b</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.665<sup>b</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> I</td>
<td valign="top" align="left" rowspan="1" colspan="1">8</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (11.1%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (25.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> II</td>
<td valign="top" align="left" rowspan="1" colspan="1">23</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (88.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">12 (60.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (42.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> III</td>
<td valign="top" align="left" rowspan="1" colspan="1">5</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (15.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Histological type</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.633</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Breast invasive ductal carcinoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">28</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (77.8%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">16 (80.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (71.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Other</td>
<td valign="top" align="left" rowspan="1" colspan="1">8</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (22.2%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Luminal type</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.086<sup>b</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.160<sup>b</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Luminal A</td>
<td valign="top" align="left" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (15.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (28.6%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Luminal B</td>
<td valign="top" align="left" rowspan="1" colspan="1">21</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (66.7%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">12 (60.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (71.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> HER2 overexpressing</td>
<td valign="top" align="left" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Triple negative</td>
<td valign="top" align="left" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (33.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (5.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>With benign breast disease</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.060</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.024</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Yes</td>
<td valign="top" align="left" rowspan="1" colspan="1">21</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (66.7%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (70.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (14.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> No</td>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (33.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (30.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (85.7%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Recurrence or metastasis</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Yes</td>
<td valign="top" align="left" rowspan="1" colspan="1">2</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (11.1%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (5.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0 (0.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> No</td>
<td valign="top" align="left" rowspan="1" colspan="1">34</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (88.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">19 (95.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (100.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p37"><p>*Fisher’s precise test; <sup>a</sup>Student’s <em>t</em>-test; <sup>b</sup><em>rank-sum</em> test; P1-value: <em>BRCA</em>+ group <em>vs</em>. the negative group; P2-value: <em>non-BRCA</em>+ group <em>vs</em>. the negative group.</p></div></div></section><p>The average onset age of BC in the <em>BRCA</em> mutation group was younger than that in the nonmutation group (44.8 ± 9.5 <em>vs.</em> 51.3 ± 6.8) (<strong><a href="#tb004" class="usa-link">Table 4</a></strong>). However, the difference was not statistically significant. The small sample size might be an important factor. We therefore included an additional 47 BC patients with family histories of BC. Among these 83 familial BC patients, 20 had mutations in <em>BRCA1/2</em> genes, 25 had <em>non-BRCA</em> mutations, and 38 had no mutations. We compared the correlations between <em>BRCA</em> mutation status and the clinical and pathological features of patients (<strong><a href="#tb005" class="usa-link">Table 5</a></strong>). The results showed that the average onset age in the <em>BRCA</em> mutation group was significantly younger than that in the nonmutation group (45.7 ± 9.6 <em>vs.</em> 51.9 ± 8.7, <em>P</em> = 0.015). Furthermore, the percentages of young BC (55.6% <em>vs.</em> 28.6%, <em>P</em> = 0.023), lymph node metastatic (70.0% <em>vs.</em> 28.9%, <em>P</em> = 0.005), clinical stage III (35.0% <em>vs.</em> 18.4%, <em>P</em> = 0.011), and triple-negative BC (40.0% <em>vs.</em> 7.9%, <em>P</em> = 0.002) were higher in the <em>BRCA</em> mutation group than in the nonmutation group. In contrast, no significant difference was detected when comparing the above clinicopathological features between the <em>non-BRCA</em> mutation group and the non-mutation group.</p>
<section class="tw xbox font-sm" id="tb005"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>Clinicopathological characteristics among 83 patients with different mutation status</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Features</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>n</em>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA+</em> (<em>n</em> = 20, %)</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>non-BRCA</em>+ (<em>n</em> = 25, %)</th>
<th valign="top" align="left" rowspan="1" colspan="1">Negative (<em>n</em> = 38, %)</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>P1-value</em>*</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<em>P2-</em>value*</th>
</tr></thead>
<tbody>
<tr><td colspan="7" valign="top" align="left" rowspan="1">
<strong>Age of onset</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Mean ± size</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">45.7 ± 9.6</td>
<td valign="top" align="left" rowspan="1" colspan="1">53.8 ± 10.7</td>
<td valign="top" align="left" rowspan="1" colspan="1">51.9 ± 8.7</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.015<sup>a</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.432<sup>a</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> ≤ 45</td>
<td valign="top" align="left" rowspan="1" colspan="1">23</td>
<td valign="top" align="left" rowspan="1" colspan="1">11 (55.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (12.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">9 (23.7%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.023</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.334</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> &gt; 45</td>
<td valign="top" align="left" rowspan="1" colspan="1">60</td>
<td valign="top" align="left" rowspan="1" colspan="1">9 (45.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">22 (88.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">29 (76.3%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Axillary lymph node metastasis</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.005</td>
<td valign="top" align="left" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Yes</td>
<td valign="top" align="left" rowspan="1" colspan="1">33</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (70.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (32.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">11 (28.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> No</td>
<td valign="top" align="left" rowspan="1" colspan="1">50</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 (30.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">17 (68.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">27 (71.1%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>TNM stage</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.011<sup>b</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.273<sup>b</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> 0 + I</td>
<td valign="top" align="left" rowspan="1" colspan="1">37</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (40.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">23 (60.5%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> II</td>
<td valign="top" align="left" rowspan="1" colspan="1">27</td>
<td valign="top" align="left" rowspan="1" colspan="1">9 (45.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">10 (40.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (21.1%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> III</td>
<td valign="top" align="left" rowspan="1" colspan="1">19</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (35.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (18.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Tumor grade</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.223<sup>b</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.986<sup>b</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> I</td>
<td valign="top" align="left" rowspan="1" colspan="1">14</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (5.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (21.1%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> II</td>
<td valign="top" align="left" rowspan="1" colspan="1">54</td>
<td valign="top" align="left" rowspan="1" colspan="1">16 (80.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">15 (60.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">23 (60.5%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> III</td>
<td valign="top" align="left" rowspan="1" colspan="1">15</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (15.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">7 (18.4%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Luminal type</strong>
</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1">0.002<sup>b</sup>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">0.293<sup>b</sup>
</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Luminal A</td>
<td valign="top" align="left" rowspan="1" colspan="1">4</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (10.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (16.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">14 (36.8%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Luminal B</td>
<td valign="top" align="left" rowspan="1" colspan="1">21</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (40.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">15 (60.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">17 (44.7%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> HER2 overexpressing</td>
<td valign="top" align="left" rowspan="1" colspan="1">11</td>
<td valign="top" align="left" rowspan="1" colspan="1">2 (10.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 (20.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 (10.5%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Triple negative</td>
<td valign="top" align="left" rowspan="1" colspan="1">12</td>
<td valign="top" align="left" rowspan="1" colspan="1">8 (40.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">1 (4.0%)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 (7.9%)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tb005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p40"><p>*Fisher’s precise test. <sup>a</sup>Student’s <em>t</em>-test; <sup>b</sup><em>rank-sum</em> test; P1-value: <em>BRCA</em>+ group <em>vs</em>. the negative group; P2-value: <em>non-BRCA</em>+ group <em>vs</em>. the negative group.</p></div></div></section></section><section id="s3h"><h3 class="pmc_sec_title">Classical pedigree analysis of hereditary BC families</h3>
<p><strong><a href="#fg006" class="usa-link">Figure 6</a></strong> shows several representative families enrolled in this study. As shown in <strong><a href="#fg006" class="usa-link">Figure 6A</a></strong>, the family included 4 BC patients, of whom 1 died and 1 suffered bilateral BC. We collected samples from other patients. The sequencing results showed that all 3 patients carried <em>BRCA2</em> p.Arg2520Term and <em>CHEK2</em> p.Ala480Thr mutations. According to the ACMG classification, <em>CHEK2</em> p.Ala480Thr is a VUS and <em>BRCA2</em> p.Arg2520Term is a pathogenic mutation. Therefore, the <em>BRCA2</em> p.Arg2520Term mutation may be the genetic pathogenic mutation of this family. The earliest onset age of BC patients in this family was 30 years of age, and the oldest was 40 years of age. The onset age of BC caused by the <em>BRCA2</em> p.Arg2520Term mutation may be earlier. In the fourth generation, 2 young family members, 26 and 22 years of age, respectively, also carried <em>BRCA2</em> p.Arg2520Term. Although they are still healthy, it was recommended that prevention and follow-up should be strengthened.</p>
<figure class="fig xbox font-sm" id="fg006"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9257317_cbm-19-850-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fe5/9257317/afab044ff60b/cbm-19-850-g006.jpg" loading="lazy" height="2463" width="707" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/fg006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The family tree of classical pedigrees in this study.</p></figcaption></figure><p>As shown in <strong><a href="#fg006" class="usa-link">Figure 6B</a></strong>, the pathogenic mutation <em>BRCA1</em> Asp1362fs was found in 1 BC patient, 1 ovarian cancer patient, and 2 healthy family members. The BC patient was diagnosed at the age of 58 years, and the ovarian cancer patient was diagnosed at the age of 63 years. BC or ovarian cancer caused by <em>BRCA1</em> Asp1362fs may develop later. It is noteworthy that their mother was not a cancer patient, while 1 of their maternal aunts (their mother’s sister) suffered from BC. Genetic testing for these patients was not available because they had died. In addition to BC and ovarian cancer, this family also had 1 esophageal cancer patient. However, there was no definite link between the occurrence of esophageal cancer and the <em>BRCA1</em> Asp1362fs mutation. The 2 healthy family members with <em>BRCA1</em> Asp1362fs were 32 and 29 years of age, respectively. They may have not reached the age of onset. However, early prevention and regular physical examination were recommended.</p>
<p><strong><a href="#fg006" class="usa-link">Figure 6C</a></strong> shows a family with 2 BC patients. Patient III.1 was diagnosed with BC at the age of 57 years. Her sister (Patient III.2) was diagnosed with BC at the age of 52 years. They both carried <em>BLM</em> p.Asp1116fs and <em>BRCA2</em> p.Ile1929Val. According to the ACMG classification, <em>BLM</em> p.Asp1116fs is a likely pathogenic mutation and <em>BRCA2</em> p.Ile1929Val is a VUS. The <em>BLM</em> gene encodes the DNA helicase RecQ protein on chromosome 15q26, which unwinds a variety of DNA substrates including Holliday junctions, and is involved in several pathways contributing to the maintenance of genome stability<sup><a href="#r40" class="usa-link" aria-describedby="r40">40</a></sup>. <em>BLM</em> p.Asp1116fs was presumably the main genetic cause of BC in this family. One of the healthy family members was also detected with <em>BLM</em> p.Asp1116fs at the age of 37 years. Because she might have a high risk of BC, we suggested that she have regular physical examinations for the possible early prevention of BC.</p>
<p>In <strong><a href="#fg006" class="usa-link">Figure 6D</a></strong>, we collected 5 samples from this family. BC patient II.1 was detected with <em>BRCA1</em> p.Glu1836fs and <em>BRIP1</em> p.Lys222Term. These 2 mutations are likely pathogenic according to the ACMG guidelines. Her mother had ovarian cancer. Because she had already died, her sample could not be collected. One healthy family member was detected with p.Glu1836fs and <em>BRIP1</em> p.Lys222Term and another with <em>BRCA1</em> p.Glu1836fs. <em>BRCA1</em> p.Glu1836fs has been reported in a Chinese BC patient<sup><a href="#r41" class="usa-link" aria-describedby="r41">41</a></sup> and recorded as pathogenic in the LOVD database (<a href="https://brcaexchange.org/variant/451386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://brcaexchange.org/variant/451386</a>). It was indicated that mutation of BRCA1 p.Glu1836fs can lead to the occurrence of BC without the mutation of <em>BRIP1</em> p.Lys222Term. The protein encoded by BRIP1 interacts with the BRCT repeats of BRCA1 protein. The bound complex is important in the normal double-strand break repair function of BRCA1<sup><a href="#r42" class="usa-link" aria-describedby="r42">42</a></sup>. In this family, healthy carriers of likely pathogenic mutations were also recommended to seek close follow-up and early prevention of BC.</p>
<p>Annual breast magnetic resonance imaging or mammography screening is recommended for younger pathogenic mutation carriers. For healthy women with <em>BRCA</em> pathogenic mutations who have no fertility requirements, chemoprevention or risk-reduction surgery is recommended to reduce the risk of BC occurrence<sup><a href="#r43" class="usa-link" aria-describedby="r43">43</a></sup>.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>We performed NGS for 116 subjects from 27 familial BC families based on the Ion Torrent S5 platform. The average sequencing depth was more than 800×. The percentage of hereditary BC in families caused by mutations in known genetic predisposition genes was approximately 48.1%, which was higher than that of other reports of familial BC<sup><a href="#r44" class="usa-link" aria-describedby="r44">44</a>–<a href="#r46" class="usa-link" aria-describedby="r46">46</a></sup>. This was probably because of the high sensitivity of amplicon-based NGS. In addition, the range of genes tested was increased in this study.</p>
<p>In this study, 43 genes were used to detect the hereditary risk of familial BC and other BC-related inherited syndromes. Most of them, such as <em>AKT1</em>, <em>APC</em>, <em>ATR</em>, <em>ATM</em>, <em>BAP1</em>, <em>BARD1</em>, <em>BLM</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>BRIP1</em>, <em>CDH1</em>, <em>CHEK2</em>, <em>EPCAM</em>, <em>ERBB2</em>, <em>ERCC1</em>, <em>FANCI</em>, <em>MLH1</em>, <em>MRE11A</em>, <em>MSH2</em>, <em>MSH6</em>, <em>MUTYH</em>, <em>NBN</em>, <em>PALB2</em>, <em>PIK3CA</em>, <em>PMS2</em>, <em>PTEN</em>, <em>RAD50</em>, <em>RAD51C</em>, <em>RAD51D</em>, <em>RET</em>, <em>STK11</em>, and <em>TP53</em> have been reported to be associated with BC susceptibilities<sup><a href="#r14" class="usa-link" aria-describedby="r14">14</a>,<a href="#r47" class="usa-link" aria-describedby="r47">47</a>–<a href="#r51" class="usa-link" aria-describedby="r51">51</a></sup>. In addition, there are still some cancer predisposition genes reported in other BC-related inherited syndromes, such as <em>CYP1B1</em>, <em>CCND1</em>, <em>CDK4</em>, <em>ERBB4</em>, <em>FANCD2</em>, <em>NOTCH1</em>, <em>SMAD4</em>, <em>XPC</em>, and <em>XRCC1</em><sup><a href="#r52" class="usa-link" aria-describedby="r52">52</a>–<a href="#r55" class="usa-link" aria-describedby="r55">55</a></sup>, most of which belong to DDR-related genes.</p>
<p><em>BRCA1</em> and <em>BRCA2</em> are 2 well-known high penetration predisposition genes in hereditary BC. Hereditary BC with <em>BRCA</em> mutations is more invasive than that without <em>BRCA</em> mutations<sup><a href="#r9" class="usa-link" aria-describedby="r9">9</a>,<a href="#r22" class="usa-link" aria-describedby="r22">22</a>,<a href="#r56" class="usa-link" aria-describedby="r56">56</a></sup>. In this study, comparative analyses of clinicopathological features also showed that patients with <em>BRCA</em> mutations had a younger age of onset, more advanced stage, and higher risk of axillary lymph node metastasis than those without mutations. The mutation prevalence of <em>BRCA</em> is distinct in different countries. In this study, <em>BRCA</em>-related families accounted for 25.9% of the 27 familial BC families. In a German study including 21,401 families with familial breast or ovarian cancers, the percentage of <em>BRCA</em>-related families was 24.0%<sup><a href="#r44" class="usa-link" aria-describedby="r44">44</a></sup>. According to another study<sup><a href="#r57" class="usa-link" aria-describedby="r57">57</a></sup>, which analyzed comparative families with ≥ 2 cases of breast and/or ovarian cancer among first- and second-degree relatives, the percentage of <em>BRCA</em>-related families was 46.2% in 78 Caucasian families, 68.9% in 29 Ashkenazi Jewish families, and 27.9% in 43 African families. The prevalence of <em>BRCA1/2</em> mutations in this study was comparably higher than those reported in other Chinese familial BC cohorts. According to previous studies<sup><a href="#r6" class="usa-link" aria-describedby="r6">6</a>,<a href="#r22" class="usa-link" aria-describedby="r22">22</a>,<a href="#r56" class="usa-link" aria-describedby="r56">56</a></sup>, the prevalence of <em>BRCA1/2</em> mutations was 12.7%–19.1% in Chinese familial BC patients, which is distinct from the prevalence of <em>BRCA1/2</em> mutations in this study. The disparity might be caused by differences in the study populations and the methods of statistical analyses. In our study, we focused on the prevalence of <em>BRCA1/2</em> mutations in each hereditary BC family, including both familial BC patients and their direct relatives. The prevalence of <em>BRCA1/2</em> mutation was significantly higher compared to those studies including familial BC patients only. In addition, different geographical areas, ethnic groups, genetic testing methods, as well as limited sample sizes might have contributed to the disparity in the prevalence of <em>BRCA1/2</em> mutations. We plan to enroll more hereditary BC families in the future to validate our findings.</p>
<p>We found that the mutation frequency of the <em>BRCA2</em> gene was 1.09 times that of the <em>BRCA1</em> gene in these BC families. In other reports based on a Chinese population, Zhang et al.<sup><a href="#r46" class="usa-link" aria-describedby="r46">46</a></sup> reported in 409 Chinese familial BC patients that the <em>BRCA2</em> mutation frequency was 1.7 times (6.6%/3.9%) higher than the <em>BRCA1</em> mutation frequency. However, this result was inconsistent with other reported findings, which indicated that the mutation frequency of the <em>BRCA1</em> gene was considerably higher than that of the <em>BRCA2</em> gene in European and American populations<sup><a href="#r57" class="usa-link" aria-describedby="r57">57</a>,<a href="#r58" class="usa-link" aria-describedby="r58">58</a></sup>. Another important difference is the penetrance of <em>BRCA</em>. It is well-documented that Western women who carry a pathogenic <em>BRCA1</em> or <em>BRCA2</em> mutation may have a 57%–65% or 45%–49% risk of developing BC by the age of 70 years<sup><a href="#r59" class="usa-link" aria-describedby="r59">59</a>,<a href="#r60" class="usa-link" aria-describedby="r60">60</a></sup>. Women of Ashkenazi Jewish and Icelandic descent who carry a <em>BRCA1/2</em> mutation have a BC risk as high as 70% by the age of 70 years<sup><a href="#r3" class="usa-link" aria-describedby="r3">3</a>,<a href="#r61" class="usa-link" aria-describedby="r61">61</a>,<a href="#r62" class="usa-link" aria-describedby="r62">62</a></sup>. However, the breast cancer risk for <em>BRCA1/2</em> mutation carriers is only 35%–49% in women from Australia, the UK, and the Republic of Korea<sup><a href="#r3" class="usa-link" aria-describedby="r3">3</a>,<a href="#r63" class="usa-link" aria-describedby="r63">63</a>,<a href="#r64" class="usa-link" aria-describedby="r64">64</a></sup>. A study based on a Chinese population<sup><a href="#r65" class="usa-link" aria-describedby="r65">65</a></sup> reported that the estimated cumulative risks of BC by the age of 70 years were 37.9% for <em>BRCA1</em> mutation carriers and 36.5% for <em>BRCA2</em> mutation carriers. The differences might be predominantly derived from the disparities in ethnic groups, which should be thoroughly investigated in a large-scale random case-control trial, especially in the Chinese population.</p>
<p>Of the 116 subjects in this study, 48.6% were found to exclusively carry mutations in <em>non-BRCA</em> genes. Testing for <em>non-BRCA</em> genes increased the detection of hereditary BC families by 22.2%. Similar results were also found in other reports. According to the Lin et al.<sup><a href="#r66" class="usa-link" aria-describedby="r66">66</a></sup> study, the mutation prevalence of <em>BRCA1/2</em> in Han Chinese patients with early onset or with a significant family history was 15.0%, and there was a 7.5% mutation of <em>non-BRCA</em> genes in women who tested negative for <em>BRCA1/2</em> mutations. In another study of German BC patients, extended testing beyond <em>BRCA1/2</em> also identified a deleterious mutation in an additional 6% of patients<sup><a href="#r67" class="usa-link" aria-describedby="r67">67</a></sup>. Our previous findings also showed that the percentage of possible disease-causing mutation carriers among BC patients with a family history increased from 21.3% to 27.7% when the sequenced genes were increased from 6 to 20<sup><a href="#r22" class="usa-link" aria-describedby="r22">22</a></sup>. Therefore, broader panel testing including more genes would significantly increase the detection percentage of mutation carriers and enhance the screening efficiency for hereditary BC.</p>
<p>We also found that <em>non-BRCA</em>-mutated BC was more likely to be accompanied by benign breast diseases. Benign breast disease is an important risk factor for the development of BC. It has been reported that women with severe atypical epithelial hyperplasia of the breasts were twice as likely to develop BC as women without such diseases<sup><a href="#r68" class="usa-link" aria-describedby="r68">68</a></sup>. The <em>non-BRCA</em> gene mutation has a weaker pathogenic effect on carcinogenesis than the <em>BRCA</em> gene<sup><a href="#r69" class="usa-link" aria-describedby="r69">69</a>,<a href="#r70" class="usa-link" aria-describedby="r70">70</a></sup>. It is reasonable that BC gradually develops from benign breast disease upon stimulation from <em>non-BRCA</em> gene mutations. This could also explain the trend to some degree that the average age of onset of BC patients with <em>non-BRCA</em> mutations was older than that of <em>BRCA</em>-mutated BC patients (55.84 ± 10.50 <em>vs.</em> 45.50 ± 9.24). These findings indicated that genetic variants of those <em>non-BRCA</em> genes also played an important role in the development of hereditary BC. These genetic variants should be further evaluated to predict the hereditary BC predisposition of high risk individuals.</p>
<p>In this study, 80.8% (21/26) of the mutated genes were DDR genes. Among these, 71.4% of DDR genes were involved in the HR pathway. In addition to <em>BRCA1/2</em> genes, the mutated HR genes also included <em>ATM</em>, <em>BAP1</em>, <em>BARD1</em>, <em>BRIP1</em>, <em>BLM</em>, <em>CHEK2</em>, <em>FANCD2</em>, <em>FANCI</em>, <em>MRE11A</em>, <em>NBN</em>, <em>PALB2</em>, <em>RAD50</em>, and <em>RAD51C</em>. The interaction between BRCA1-BARD1, the BRCA2-PALB2 complex, and the recombinant enzyme RAD51 is an important aspect in the HR process<sup><a href="#r71" class="usa-link" aria-describedby="r71">71</a></sup>. The most important function of HR genes is to repair DNA double strand breaks (DSBs), which are the most serious type of DNA damage<sup><a href="#r72" class="usa-link" aria-describedby="r72">72</a>,<a href="#r73" class="usa-link" aria-describedby="r73">73</a></sup>. Breast cells with homologous recombination repair defects may not be able to initiate HR to repair DSBs. Abnormal repair may lead to chromosome loss, transposition, and other changes. Over time, under the influence of multiple carcinogenic factors, the accumulation of errors leads to the development of BC<sup><a href="#r74" class="usa-link" aria-describedby="r74">74</a></sup>. The mutated MMR genes included <em>MLH1</em>, <em>MSH2</em>, <em>MSH6</em>, <em>EPCAM</em>, and <em>PMS2</em>, accounting for 23.8% of the DDR genes. MMR genes prevent mutational events through correction of mismatched bases during DNA replication. Genetic defects in the DNA MMR system result in DNA replication errors, including base substitutions and insertion-deletion loops, known as microsatellite instability<sup><a href="#r75" class="usa-link" aria-describedby="r75">75</a></sup>. Germline mutations in MMR genes can give rise to Lynch syndrome (LS), an autosomal-dominant cancer predisposition syndrome that increases the risk for several forms of malignancy, including colorectal (lifetime cancer risk, 70%–80%), endometrial (50%–60%), stomach cancer (13%–19%), and ovarian cancer (9%–14%). BC incidence has been found to be increased in patients with Lynch syndrome<sup><a href="#r76" class="usa-link" aria-describedby="r76">76</a></sup>. MMR genes belong to low penetrance genes associated with BC. Studies have suggested that there might be a functional overlap between the MMR and FA-BRCA pathways<sup><a href="#r77" class="usa-link" aria-describedby="r77">77</a>,<a href="#r78" class="usa-link" aria-describedby="r78">78</a></sup>. Furthermore, 19.2% of the mutated genes were driver genes, including <em>APC</em>, <em>CDH1</em>, <em>RET</em>, <em>STK11</em>, and <em>TP53</em>. Driver gene mutations promote cancer progression and have major impacts on patient clinical outcomes. Further research on these genes in BC tissue may be warranted. Other studies have shown that the mutation clonality of driver genes was prognostic and predictive for BC patients<sup><a href="#r79" class="usa-link" aria-describedby="r79">79</a>,<a href="#r80" class="usa-link" aria-describedby="r80">80</a></sup>.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusions</h2>
<p>In conclusion, this study primarily compared germline mutation profiling among 27 Chinese familial/hereditary BC families to comprehensively evaluate the genetic variants and clinical significance of 43 BC predisposition genes with different penetration rates in carcinogenesis. We found that in addition to <em>BRCA1/2</em>, genetic variants in <em>non-BRCA</em> genes, especially DDR genes, played significant roles in the development of Chinese familial/hereditary BC, which implied the indispensable significance of more extensive multiple-gene panel testing in genetic screening of hereditary BC families. People with <em>non-BRCA</em> gene mutations are more likely to suffer from BC accompanied by benign breast diseases because <em>non-BRCA</em> gene mutations have a weaker pathogenic effect on carcinogenesis than <em>BRCA</em> genes. Therefore, more intensive mammary screening of <em>non-BRCA</em> mutation-bearing individuals in hereditary BC families is recommended to increase the efficacy of early diagnosis and early treatment of BC. However, this study was limited by a small sample size from a single center. A larger multicenter study in a Chinese population should be conducted to validate the findings of this study.</p></section><section id="s6"><h2 class="pmc_sec_title">Supporting Information</h2>
<section class="sm xbox font-sm" id="cbm-19-850-s001"><div class="media p" id="d64e4021"><div class="caption">
<a href="/articles/instance/9257317/bin/cbm-19-850-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (82.5KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors thank Campian Jian Li from Washington University School of Medicine for providing constructive suggestions to this manuscript.</p></section><section id="s7"><h2 class="pmc_sec_title">Grant support</h2>
<p>This work was supported by the National Natural Science Foundation of China (Grant Nos. 82072588, 82002601, 81872143, and 81702280); the National Science and Technology Support Program of China (Grant Nos. 2015BAI12B15 and 2018ZX09201015); the National Key Research and Development Program of China; the Net Construction of Human Genetic Resource Bio-bank in North China (2016YFC1201703), the Projects of Science and Technology of Tianjin (Grant Nos. 13ZCZCSY20300 and 18JCQNJC82700), and the Key Project of Tianjin Health and Family Planning Commission (Grant No. 16KG126).</p></section><section id="sec25"><h2 class="pmc_sec_title">Conflict of interest statement</h2>
<p>No potential conflicts of interest are disclosed.</p></section><section id="s8"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceived and designed the analysis: Jinpu Yu and Juntian Liu.</p>
<p>Collected the data: Li Dong, Hailian Zhang, Huan Zhang, Yingnan Ye, Yanan Cheng, Lei Han, Lijuan Li, Lijuan Wei, and Shixia Li.</p>
<p>Contributed data or analysis tools: Lei Han and Yandong Cao.</p>
<p>Performed the analysis: Li Dong, Hailian Zhang, and Huan Zhang.</p>
<p>Wrote the paper: Li Dong, Hailian Zhang, and Huan Zhang.</p>
<p>Other contribution: Xishan Hao gave guidance and help on the design of this study.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="r1">
<span class="label">1.</span><cite>Lynch HT, Conway T, Fitzgibbons RJ, Schreiman J, Watson P, Marcus J, et al.  Age-of-onset heterogeneity in hereditary breast cancer: minimal clues for diagnosis. Breast Cancer Res Treat. 1988;12:275–85. doi: 10.1007/BF01811240.</cite> [<a href="https://doi.org/10.1007/BF01811240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3228590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Age-of-onset%20heterogeneity%20in%20hereditary%20breast%20cancer:%20minimal%20clues%20for%20diagnosis&amp;author=HT%20Lynch&amp;author=T%20Conway&amp;author=RJ%20Fitzgibbons&amp;author=J%20Schreiman&amp;author=P%20Watson&amp;volume=12&amp;publication_year=1988&amp;pages=275-85&amp;pmid=3228590&amp;doi=10.1007/BF01811240&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r2">
<span class="label">2.</span><cite>O’Donovan PJ, Livingston DM. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis. 2010;31:961–7. doi: 10.1093/carcin/bgq069.</cite> [<a href="https://doi.org/10.1093/carcin/bgq069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20400477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=BRCA1%20and%20BRCA2:%20breast/ovarian%20cancer%20susceptibility%20gene%20products%20and%20participants%20in%20DNA%20double-strand%20break%20repair&amp;author=PJ%20O%E2%80%99Donovan&amp;author=DM%20Livingston&amp;volume=31&amp;publication_year=2010&amp;pages=961-7&amp;pmid=20400477&amp;doi=10.1093/carcin/bgq069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r3">
<span class="label">3.</span><cite>King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–6. doi: 10.1126/science.1088759.</cite> [<a href="https://doi.org/10.1126/science.1088759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14576434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Breast%20and%20ovarian%20cancer%20risks%20due%20to%20inherited%20mutations%20in%20BRCA1%20and%20BRCA2&amp;author=MC%20King&amp;author=JH%20Marks&amp;author=JB%20Mandell&amp;volume=302&amp;publication_year=2003&amp;pages=643-6&amp;pmid=14576434&amp;doi=10.1126/science.1088759&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r4">
<span class="label">4.</span><cite>Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007;7:937–48. doi: 10.1038/nrc2054.</cite> [<a href="https://doi.org/10.1038/nrc2054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18034184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Breast%20cancer%20risk%20associated%20with%20BRCA1%20and%20BRCA2%20in%20diverse%20populations&amp;author=JD%20Fackenthal&amp;author=OI%20Olopade&amp;volume=7&amp;publication_year=2007&amp;pages=937-48&amp;pmid=18034184&amp;doi=10.1038/nrc2054&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r5">
<span class="label">5.</span><cite>Lynch HT, Lynch JF. Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet Cytogenet. 1986;22:369–71. doi: 10.1016/0165-4608(86)90032-4.</cite> [<a href="https://doi.org/10.1016/0165-4608(86)90032-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3731052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet%20Cytogenet&amp;title=Breast%20cancer%20genetics%20in%20an%20oncology%20clinic:%20328%20consecutive%20patients&amp;author=HT%20Lynch&amp;author=JF%20Lynch&amp;volume=22&amp;publication_year=1986&amp;pages=369-71&amp;pmid=3731052&amp;doi=10.1016/0165-4608(86)90032-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r6">
<span class="label">6.</span><cite>Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J, et al.  Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat. 2016;158:455–62. doi: 10.1007/s10549-016-3902-0.</cite> [<a href="https://doi.org/10.1007/s10549-016-3902-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27393621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Comprehensive%20analysis%20of%20BRCA1%20and%20BRCA2%20germline%20mutations%20in%20a%20large%20cohort%20of%205931%20Chinese%20women%20with%20breast%20cancer&amp;author=J%20Zhang&amp;author=J%20Sun&amp;author=J%20Chen&amp;author=L%20Yao&amp;author=T%20Ouyang&amp;volume=158&amp;publication_year=2016&amp;pages=455-62&amp;pmid=27393621&amp;doi=10.1007/s10549-016-3902-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r7">
<span class="label">7.</span><cite>Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al.  Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Cancer Epidemiol Biomarkers Prev. 2012;21:134–47. doi: 10.1158/1055-9965.EPI-11-0775.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-11-0775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3272407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22144499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Pathology%20of%20breast%20and%20ovarian%20cancers%20among%20BRCA1%20and%20BRCA2%20mutation%20carriers:%20results%20from%20the%20Consortium%20of%20Investigators%20of%20Modifiers%20of%20BRCA1/2%20(CIMBA)&amp;author=N%20Mavaddat&amp;author=D%20Barrowdale&amp;author=IL%20Andrulis&amp;author=SM%20Domchek&amp;author=D%20Eccles&amp;volume=21&amp;publication_year=2012&amp;pages=134-47&amp;pmid=22144499&amp;doi=10.1158/1055-9965.EPI-11-0775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r8">
<span class="label">8.</span><cite>Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480–90. doi: 10.1200/JCO.2002.20.6.1480.</cite> [<a href="https://doi.org/10.1200/JCO.2002.20.6.1480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11896095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Clinical%20characteristics%20of%20individuals%20with%20germline%20mutations%20in%20BRCA1%20and%20BRCA2:%20analysis%20of%2010,000%20individuals&amp;author=TS%20Frank&amp;author=AM%20Deffenbaugh&amp;author=JE%20Reid&amp;author=M%20Hulick&amp;author=BE%20Ward&amp;volume=20&amp;publication_year=2002&amp;pages=1480-90&amp;pmid=11896095&amp;doi=10.1200/JCO.2002.20.6.1480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r9">
<span class="label">9.</span><cite>Valachis A, Nearchou AD, Lind P. Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014;144:443–55. doi: 10.1007/s10549-014-2890-1.</cite> [<a href="https://doi.org/10.1007/s10549-014-2890-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24567198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Surgical%20management%20of%20breast%20cancer%20in%20BRCA-mutation%20carriers:%20a%20systematic%20review%20and%20meta-analysis&amp;author=A%20Valachis&amp;author=AD%20Nearchou&amp;author=P%20Lind&amp;volume=144&amp;publication_year=2014&amp;pages=443-55&amp;pmid=24567198&amp;doi=10.1007/s10549-014-2890-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r10">
<span class="label">10.</span><cite>Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, et al.  Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121:269–75. doi: 10.1002/cncr.29041.</cite> [<a href="https://doi.org/10.1002/cncr.29041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4293332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25224030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Cancers%20associated%20with%20BRCA1%20and%20BRCA2%20mutations%20other%20than%20breast%20and%20ovarian&amp;author=J%20Mersch&amp;author=MA%20Jackson&amp;author=M%20Park&amp;author=D%20Nebgen&amp;author=SK%20Peterson&amp;volume=121&amp;publication_year=2015&amp;pages=269-75&amp;pmid=25224030&amp;doi=10.1002/cncr.29041&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r11">
<span class="label">11.</span><cite>Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, et al.  Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res. 2016;18:112. doi: 10.1186/s13058-016-0768-3.</cite> [<a href="https://doi.org/10.1186/s13058-016-0768-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5106833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27836010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Inheritance%20of%20deleterious%20mutations%20at%20both%20BRCA1%20and%20BRCA2%20in%20an%20international%20sample%20of%2032,295%20women&amp;author=TR%20Rebbeck&amp;author=TM%20Friebel&amp;author=N%20Mitra&amp;author=F%20Wan&amp;author=S%20Chen&amp;volume=18&amp;publication_year=2016&amp;pages=112&amp;pmid=27836010&amp;doi=10.1186/s13058-016-0768-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r12">
<span class="label">12.</span><cite>Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, et al.  Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372:2243–57. doi: 10.1056/NEJMsr1501341.</cite> [<a href="https://doi.org/10.1056/NEJMsr1501341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4610139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26014596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Gene-panel%20sequencing%20and%20the%20prediction%20of%20breast-cancer%20risk&amp;author=DF%20Easton&amp;author=PD%20Pharoah&amp;author=AC%20Antoniou&amp;author=M%20Tischkowitz&amp;author=SV%20Tavtigian&amp;volume=372&amp;publication_year=2015&amp;pages=2243-57&amp;pmid=26014596&amp;doi=10.1056/NEJMsr1501341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r13">
<span class="label">13.</span><cite>Kean S. Breast cancer. The ‘other’ breast cancer genes. Science. 2014;343:1457–9. doi: 10.1126/science.343.6178.1457.</cite> [<a href="https://doi.org/10.1126/science.343.6178.1457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24675950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Breast%20cancer.%20The%20%E2%80%98other%E2%80%99%20breast%20cancer%20genes&amp;author=S%20Kean&amp;volume=343&amp;publication_year=2014&amp;pages=1457-9&amp;pmid=24675950&amp;doi=10.1126/science.343.6178.1457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r14">
<span class="label">14.</span><cite>Sun J, Meng H, Yao L, Lv M, Bai J, Zhang J, et al.  Germline Mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res. 2017;23:6113–9. doi: 10.1158/1078-0432.CCR-16-3227.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-3227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28724667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Germline%20Mutations%20in%20cancer%20susceptibility%20genes%20in%20a%20large%20series%20of%20unselected%20breast%20cancer%20patients&amp;author=J%20Sun&amp;author=H%20Meng&amp;author=L%20Yao&amp;author=M%20Lv&amp;author=J%20Bai&amp;volume=23&amp;publication_year=2017&amp;pages=6113-9&amp;pmid=28724667&amp;doi=10.1158/1078-0432.CCR-16-3227&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r15">
<span class="label">15.</span><cite>Majidinia M, Yousefi B. DNA repair and damage pathways in breast cancer development and therapy. DNA Repair (Amst) 2017;54:22–9. doi: 10.1016/j.dnarep.2017.03.009.</cite> [<a href="https://doi.org/10.1016/j.dnarep.2017.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28437752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=DNA%20Repair%20(Amst)&amp;title=DNA%20repair%20and%20damage%20pathways%20in%20breast%20cancer%20development%20and%20therapy&amp;author=M%20Majidinia&amp;author=B%20Yousefi&amp;volume=54&amp;publication_year=2017&amp;pages=22-9&amp;pmid=28437752&amp;doi=10.1016/j.dnarep.2017.03.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r16">
<span class="label">16.</span><cite>Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643–9. doi: 10.1038/25292.</cite> [<a href="https://doi.org/10.1038/25292" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9872311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genetic%20instabilities%20in%20human%20cancers&amp;author=C%20Lengauer&amp;author=KW%20Kinzler&amp;author=B%20Vogelstein&amp;volume=396&amp;publication_year=1998&amp;pages=643-9&amp;pmid=9872311&amp;doi=10.1038/25292&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r17">
<span class="label">17.</span><cite>Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70. doi: 10.1038/nature11412.</cite> [<a href="https://doi.org/10.1038/nature11412" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3465532/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23000897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive%20molecular%20portraits%20of%20human%20breast%20tumours&amp;volume=490&amp;publication_year=2012&amp;pages=61-70&amp;pmid=23000897&amp;doi=10.1038/nature11412&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r18">
<span class="label">18.</span><cite>Economopoulou P, Dimitriadis G, Psyrri A. Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev. 2015;41:1–8. doi: 10.1016/j.ctrv.2014.10.008.</cite> [<a href="https://doi.org/10.1016/j.ctrv.2014.10.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25467110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Treat%20Rev&amp;title=Beyond%20BRCA:%20new%20hereditary%20breast%20cancer%20susceptibility%20genes&amp;author=P%20Economopoulou&amp;author=G%20Dimitriadis&amp;author=A%20Psyrri&amp;volume=41&amp;publication_year=2015&amp;pages=1-8&amp;pmid=25467110&amp;doi=10.1016/j.ctrv.2014.10.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r19">
<span class="label">19.</span><cite>Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, et al.  The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486:400–4. doi: 10.1038/nature11017.</cite> [<a href="https://doi.org/10.1038/nature11017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3428862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22722201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20landscape%20of%20cancer%20genes%20and%20mutational%20processes%20in%20breast%20cancer&amp;author=PJ%20Stephens&amp;author=PS%20Tarpey&amp;author=H%20Davies&amp;author=P%20Van%20Loo&amp;author=C%20Greenman&amp;volume=486&amp;publication_year=2012&amp;pages=400-4&amp;pmid=22722201&amp;doi=10.1038/nature11017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r20">
<span class="label">20.</span><cite>Zhang X, Liang Z, Wang S, Lu S, Song Y, Cheng Y, et al.  Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology. Cancer Biol Med. 2019;16:189–204. doi: 10.20892/j.issn.2095-3941.2018.0142.</cite> [<a href="https://doi.org/10.20892/j.issn.2095-3941.2018.0142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6528448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31119060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Biol%20Med&amp;title=Application%20of%20next-generation%20sequencing%20technology%20to%20precision%20medicine%20in%20cancer:%20joint%20consensus%20of%20the%20Tumor%20Biomarker%20Committee%20of%20the%20Chinese%20Society%20of%20Clinical%20Oncology&amp;author=X%20Zhang&amp;author=Z%20Liang&amp;author=S%20Wang&amp;author=S%20Lu&amp;author=Y%20Song&amp;volume=16&amp;publication_year=2019&amp;pages=189-204&amp;pmid=31119060&amp;doi=10.20892/j.issn.2095-3941.2018.0142&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r21">
<span class="label">21.</span><cite>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. doi: 10.1038/gim.2015.30.</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20a%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S%20Richards&amp;author=N%20Aziz&amp;author=S%20Bale&amp;author=D%20Bick&amp;author=S%20Das&amp;volume=17&amp;publication_year=2015&amp;pages=405-24&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r22">
<span class="label">22.</span><cite>Dong L, Wu N, Wang S, Cheng Y, Han L, Zhao J, et al.  Detection of novel germline mutations in six breast cancer predisposition genes by targeted next-generation sequencing. Hum Mutat. 2018;39:1442–55. doi: 10.1002/humu.23597.</cite> [<a href="https://doi.org/10.1002/humu.23597" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30039884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Detection%20of%20novel%20germline%20mutations%20in%20six%20breast%20cancer%20predisposition%20genes%20by%20targeted%20next-generation%20sequencing&amp;author=L%20Dong&amp;author=N%20Wu&amp;author=S%20Wang&amp;author=Y%20Cheng&amp;author=L%20Han&amp;volume=39&amp;publication_year=2018&amp;pages=1442-55&amp;pmid=30039884&amp;doi=10.1002/humu.23597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r23">
<span class="label">23.</span><cite>Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 1997;11:68–76.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9034168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J&amp;title=A%20superfamily%20of%20conserved%20domains%20in%20DNA%20damage-responsive%20cell%20cycle%20checkpoint%20proteins&amp;author=P%20Bork&amp;author=K%20Hofmann&amp;author=P%20Bucher&amp;author=AF%20Neuwald&amp;author=SF%20Altschul&amp;volume=11&amp;publication_year=1997&amp;pages=68-76&amp;pmid=9034168&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r24">
<span class="label">24.</span><cite>Callebaut I, Mornon JP. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 1997;400:25–30. doi: 10.1016/s0014-5793(96)01312-9.</cite> [<a href="https://doi.org/10.1016/s0014-5793(96)01312-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9000507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Lett&amp;title=From%20BRCA1%20to%20RAP1:%20a%20widespread%20BRCT%20module%20closely%20associated%20with%20DNA%20repair&amp;author=I%20Callebaut&amp;author=JP%20Mornon&amp;volume=400&amp;publication_year=1997&amp;pages=25-30&amp;pmid=9000507&amp;doi=10.1016/s0014-5793(96)01312-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r25">
<span class="label">25.</span><cite>Marston NJ, Richards WJ, Hughes D, Bertwistle D, Marshall CJ, Ashworth A. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol. 1999;19:4633–42. doi: 10.1128/mcb.19.7.4633.</cite> [<a href="https://doi.org/10.1128/mcb.19.7.4633" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC84261/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10373512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biol&amp;title=Interaction%20between%20the%20product%20of%20the%20breast%20cancer%20susceptibility%20gene%20BRCA2%20and%20DSS1,%20a%20protein%20functionally%20conserved%20from%20yeast%20to%20mammals&amp;author=NJ%20Marston&amp;author=WJ%20Richards&amp;author=D%20Hughes&amp;author=D%20Bertwistle&amp;author=CJ%20Marshall&amp;volume=19&amp;publication_year=1999&amp;pages=4633-42&amp;pmid=10373512&amp;doi=10.1128/mcb.19.7.4633&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r26">
<span class="label">26.</span><cite>German J, Sanz MM, Ciocci S, Ye TZ, Ellis NA. Syndrome-causing mutations of the BLM gene in persons in the Bloom’s Syndrome Registry. Hum Mutat. 2007;28:743–53. doi: 10.1002/humu.20501.</cite> [<a href="https://doi.org/10.1002/humu.20501" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17407155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Syndrome-causing%20mutations%20of%20the%20BLM%20gene%20in%20persons%20in%20the%20Bloom%E2%80%99s%20Syndrome%20Registry&amp;author=J%20German&amp;author=MM%20Sanz&amp;author=S%20Ciocci&amp;author=TZ%20Ye&amp;author=NA%20Ellis&amp;volume=28&amp;publication_year=2007&amp;pages=743-53&amp;pmid=17407155&amp;doi=10.1002/humu.20501&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r27">
<span class="label">27.</span><cite>Devlin LA, Graham CA, Price JH, Morrison PJ. Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts. Ulster Med J. 2008;77:25–30.</cite> [<a href="/articles/PMC2397009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18269114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ulster%20Med%20J&amp;title=Germline%20MSH6%20mutations%20are%20more%20prevalent%20in%20endometrial%20cancer%20patient%20cohorts%20than%20hereditary%20non%20polyposis%20colorectal%20cancer%20cohorts&amp;author=LA%20Devlin&amp;author=CA%20Graham&amp;author=JH%20Price&amp;author=PJ%20Morrison&amp;volume=77&amp;publication_year=2008&amp;pages=25-30&amp;pmid=18269114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r28">
<span class="label">28.</span><cite>Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al-Mulla F, et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet. 2014;46:107–15. doi: 10.1038/ng.2854.</cite> [<a href="https://doi.org/10.1038/ng.2854" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4294709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24362816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Application%20of%20a%205-tiered%20scheme%20for%20standardized%20classification%20of%202,360%20unique%20mismatch%20repair%20gene%20variants%20in%20the%20InSiGHT%20locus-specific%20database&amp;author=BA%20Thompson&amp;author=AB%20Spurdle&amp;author=JP%20Plazzer&amp;author=MS%20Greenblatt&amp;author=K%20Akagi&amp;volume=46&amp;publication_year=2014&amp;pages=107-15&amp;pmid=24362816&amp;doi=10.1038/ng.2854&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r29">
<span class="label">29.</span><cite>Yuan Y, Han HJ, Zheng S, Park JG. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer. Dis Colon Rectum. 1998;41:434–40. doi: 10.1007/BF02235756.</cite> [<a href="https://doi.org/10.1007/BF02235756" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9559627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dis%20Colon%20Rectum&amp;title=Germline%20mutations%20of%20hMLH1%20and%20hMSH2%20genes%20in%20patients%20with%20suspected%20hereditary%20nonpolyposis%20colorectal%20cancer%20and%20sporadic%20early-onset%20colorectal%20cancer&amp;author=Y%20Yuan&amp;author=HJ%20Han&amp;author=S%20Zheng&amp;author=JG%20Park&amp;volume=41&amp;publication_year=1998&amp;pages=434-40&amp;pmid=9559627&amp;doi=10.1007/BF02235756&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r30">
<span class="label">30.</span><cite>Nomura S, Sugano K, Kashiwabara H, Taniguchi T, Fukayama N, Fujita S, et al.  Enhanced detection of deleterious and other germline mutations of hMSH2 and hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Biochem Biophys Res Commun. 2000;271:120–9. doi: 10.1006/bbrc.2000.2547.</cite> [<a href="https://doi.org/10.1006/bbrc.2000.2547" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10777691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Enhanced%20detection%20of%20deleterious%20and%20other%20germline%20mutations%20of%20hMSH2%20and%20hMLH1%20in%20Japanese%20hereditary%20nonpolyposis%20colorectal%20cancer%20kindreds&amp;author=S%20Nomura&amp;author=K%20Sugano&amp;author=H%20Kashiwabara&amp;author=T%20Taniguchi&amp;author=N%20Fukayama&amp;volume=271&amp;publication_year=2000&amp;pages=120-9&amp;pmid=10777691&amp;doi=10.1006/bbrc.2000.2547&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r31">
<span class="label">31.</span><cite>Banno K, Susumu N, Hirao T, Yanokura M, Hirasawa A, Aoki D, et al.  Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet. 2003;146:58–65. doi: 10.1016/s0165-4608(03)00157-2.</cite> [<a href="https://doi.org/10.1016/s0165-4608(03)00157-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14499697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet%20Cytogenet&amp;title=Identification%20of%20germline%20MSH2%20gene%20mutations%20in%20endometrial%20cancer%20not%20fulfilling%20the%20new%20clinical%20criteria%20for%20hereditary%20nonpolyposis%20colorectal%20cancer&amp;author=K%20Banno&amp;author=N%20Susumu&amp;author=T%20Hirao&amp;author=M%20Yanokura&amp;author=A%20Hirasawa&amp;volume=146&amp;publication_year=2003&amp;pages=58-65&amp;pmid=14499697&amp;doi=10.1016/s0165-4608(03)00157-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r32">
<span class="label">32.</span><cite>Stojcev Z, Banasiewicz T, Kaszuba M, Sikorski A, Szczepkowski M, Bobkiewicz A, et al.  Development of a new, simple and cost-effective diagnostic tool for genetic screening of hereditary colorectal cancer--the DNA microarray assay. Acta Biochim Pol. 2013;60:195–8.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/23741719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Biochim%20Pol&amp;title=Development%20of%20a%20new,%20simple%20and%20cost-effective%20diagnostic%20tool%20for%20genetic%20screening%20of%20hereditary%20colorectal%20cancer--the%20DNA%20microarray%20assay&amp;author=Z%20Stojcev&amp;author=T%20Banasiewicz&amp;author=M%20Kaszuba&amp;author=A%20Sikorski&amp;author=M%20Szczepkowski&amp;volume=60&amp;publication_year=2013&amp;pages=195-8&amp;pmid=23741719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r33">
<span class="label">33.</span><cite>Romei C, Tacito A, Molinaro E, Agate L, Bottici V, Viola D, et al.  Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer? Clin Endocrinol (Oxf) 2015;82:892–9. doi: 10.1111/cen.12686.</cite> [<a href="https://doi.org/10.1111/cen.12686" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25440022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Endocrinol%20(Oxf)&amp;title=Twenty%20years%20of%20lesson%20learning:%20how%20does%20the%20RET%20genetic%20screening%20test%20impact%20the%20clinical%20management%20of%20medullary%20thyroid%20cancer?&amp;author=C%20Romei&amp;author=A%20Tacito&amp;author=E%20Molinaro&amp;author=L%20Agate&amp;author=V%20Bottici&amp;volume=82&amp;publication_year=2015&amp;pages=892-9&amp;pmid=25440022&amp;doi=10.1111/cen.12686&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r34">
<span class="label">34.</span><cite>Frank-Raue K, Rondot S, Schulze E, Raue F. Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Clin Lab. 2007;53:273–82.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/17605401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Lab&amp;title=Change%20in%20the%20spectrum%20of%20RET%20mutations%20diagnosed%20between%201994%20and%202006&amp;author=K%20Frank-Raue&amp;author=S%20Rondot&amp;author=E%20Schulze&amp;author=F%20Raue&amp;volume=53&amp;publication_year=2007&amp;pages=273-82&amp;pmid=17605401&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r35">
<span class="label">35.</span><cite>Carter TC, Kay DM, Browne ML, Liu A, Romitti PA, Kuehn D, et al.  Hirschsprung’s disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation. J Hum Genet. 2012;57:485–93. doi: 10.1038/jhg.2012.54.</cite> [<a href="https://doi.org/10.1038/jhg.2012.54" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3503526/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22648184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hum%20Genet&amp;title=Hirschsprung%E2%80%99s%20disease%20and%20variants%20in%20genes%20that%20regulate%20enteric%20neural%20crest%20cell%20proliferation,%20migration%20and%20differentiation&amp;author=TC%20Carter&amp;author=DM%20Kay&amp;author=ML%20Browne&amp;author=A%20Liu&amp;author=PA%20Romitti&amp;volume=57&amp;publication_year=2012&amp;pages=485-93&amp;pmid=22648184&amp;doi=10.1038/jhg.2012.54&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r36">
<span class="label">36.</span><cite>Yokota T, Serizawa M, Hosokawa A, Kusafuka K, Mori K, Sugiyama T, et al.  PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue. BMC Cancer. 2018;18:826. doi: 10.1186/s12885-018-4733-7.</cite> [<a href="https://doi.org/10.1186/s12885-018-4733-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6097210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30115035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=PIK3CA%20mutation%20is%20a%20favorable%20prognostic%20factor%20in%20esophageal%20cancer:%20molecular%20profile%20by%20next-generation%20sequencing%20using%20surgically%20resected%20formalin-fixed,%20paraffin-embedded%20tissue&amp;author=T%20Yokota&amp;author=M%20Serizawa&amp;author=A%20Hosokawa&amp;author=K%20Kusafuka&amp;author=K%20Mori&amp;volume=18&amp;publication_year=2018&amp;pages=826&amp;pmid=30115035&amp;doi=10.1186/s12885-018-4733-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r37">
<span class="label">37.</span><cite>Kovaleva V, Geissler AL, Lutz L, Fritsch R, Makowiec F, Wiesemann S, et al.  Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing. Mol Cancer. 2016;15:63. doi: 10.1186/s12943-016-0549-8.</cite> [<a href="https://doi.org/10.1186/s12943-016-0549-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5069823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27756406/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer&amp;title=Spatio-temporal%20mutation%20profiles%20of%20case-matched%20colorectal%20carcinomas%20and%20their%20metastases%20reveal%20unique%20de%20novo%20mutations%20in%20metachronous%20lung%20metastases%20by%20targeted%20next%20generation%20sequencing&amp;author=V%20Kovaleva&amp;author=AL%20Geissler&amp;author=L%20Lutz&amp;author=R%20Fritsch&amp;author=F%20Makowiec&amp;volume=15&amp;publication_year=2016&amp;pages=63&amp;pmid=27756406&amp;doi=10.1186/s12943-016-0549-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r38">
<span class="label">38.</span><cite>Han ZY, Qiu CG, Chen QH, Zhu Y, Zhu DL. [Mutation screening of RET proto-oncogene in Chinese sporadic patients with pheochromocytoma] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006;23:320–2.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16767674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua%20Yi%20Xue%20Yi%20Chuan%20Xue%20Za%20Zhi&amp;title=%5BMutation%20screening%20of%20RET%20proto-oncogene%20in%20Chinese%20sporadic%20patients%20with%20pheochromocytoma%5D&amp;author=ZY%20Han&amp;author=CG%20Qiu&amp;author=QH%20Chen&amp;author=Y%20Zhu&amp;author=DL%20Zhu&amp;volume=23&amp;publication_year=2006&amp;pages=320-2&amp;pmid=16767674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r39">
<span class="label">39.</span><cite>French CA, Tambini CE, Thacker J. Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion. J Biol Chem. 2003;278:45445–50. doi: 10.1074/jbc.M308621200.</cite> [<a href="https://doi.org/10.1074/jbc.M308621200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12966089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&amp;title=Identification%20of%20functional%20domains%20in%20the%20RAD51L2%20(RAD51C)%20protein%20and%20its%20requirement%20for%20gene%20conversion&amp;author=CA%20French&amp;author=CE%20Tambini&amp;author=J%20Thacker&amp;volume=278&amp;publication_year=2003&amp;pages=45445-50&amp;pmid=12966089&amp;doi=10.1074/jbc.M308621200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r40">
<span class="label">40.</span><cite>Alzahrani FA, Ahmed F, Sharma M, Rehan M, Mahfuz M, Baeshen MN, et al.  Investigating the pathogenic SNPs in BLM helicase and their biological consequences by computational approach. Sci Rep. 2020;10:12377.  doi: 10.1038/s41598-020-69033-8.</cite> [<a href="https://doi.org/10.1038/s41598-020-69033-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7378827/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32704157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Investigating%20the%20pathogenic%20SNPs%20in%20BLM%20helicase%20and%20their%20biological%20consequences%20by%20computational%20approach&amp;author=FA%20Alzahrani&amp;author=F%20Ahmed&amp;author=M%20Sharma&amp;author=M%20Rehan&amp;author=M%20Mahfuz&amp;volume=10&amp;publication_year=2020&amp;pages=12377&amp;pmid=32704157&amp;doi=10.1038/s41598-020-69033-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r41">
<span class="label">41.</span><cite>Wang C, Zhang J, Wang Y, Ouyang T, Li J, Wang T, et al.  Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer. Ann Oncol. 2015;26:523–8. doi: 10.1093/annonc/mdu559.</cite> [<a href="https://doi.org/10.1093/annonc/mdu559" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25480878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Prevalence%20of%20BRCA1%20mutations%20and%20responses%20to%20neoadjuvant%20chemotherapy%20among%20BRCA1%20carriers%20and%20non-carriers%20with%20triple-negative%20breast%20cancer&amp;author=C%20Wang&amp;author=J%20Zhang&amp;author=Y%20Wang&amp;author=T%20Ouyang&amp;author=J%20Li&amp;volume=26&amp;publication_year=2015&amp;pages=523-8&amp;pmid=25480878&amp;doi=10.1093/annonc/mdu559&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r42">
<span class="label">42.</span><cite>Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, et al.  The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet. 2005;37:931–3. doi: 10.1038/ng1624.</cite> [<a href="https://doi.org/10.1038/ng1624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16116424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=The%20BRCA1-interacting%20helicase%20BRIP1%20is%20deficient%20in%20Fanconi%20anemia&amp;author=O%20Levran&amp;author=C%20Attwooll&amp;author=RT%20Henry&amp;author=KL%20Milton&amp;author=K%20Neveling&amp;volume=37&amp;publication_year=2005&amp;pages=931-3&amp;pmid=16116424&amp;doi=10.1038/ng1624&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r43">
<span class="label">43.</span><cite>Jatoi I. Risk-reducing options for women with a hereditary breast cancer predisposition. Eur J Breast Health. 2018;14:189–93. doi: 10.5152/ejbh.2018.4324.</cite> [<a href="https://doi.org/10.5152/ejbh.2018.4324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6170022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30288491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Breast%20Health&amp;title=Risk-reducing%20options%20for%20women%20with%20a%20hereditary%20breast%20cancer%20predisposition&amp;author=I%20Jatoi&amp;volume=14&amp;publication_year=2018&amp;pages=189-93&amp;pmid=30288491&amp;doi=10.5152/ejbh.2018.4324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r44">
<span class="label">44.</span><cite>Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, et al.  Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016;53:465–71. doi: 10.1136/jmedgenet-2015-103672.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2015-103672" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26928436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Prevalence%20of%20BRCA1/2%20germline%20mutations%20in%2021%20401%20families%20with%20breast%20and%20ovarian%20cancer&amp;author=K%20Kast&amp;author=K%20Rhiem&amp;author=B%20Wappenschmidt&amp;author=E%20Hahnen&amp;author=J%20Hauke&amp;volume=53&amp;publication_year=2016&amp;pages=465-71&amp;pmid=26928436&amp;doi=10.1136/jmedgenet-2015-103672&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r45">
<span class="label">45.</span><cite>Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, et al.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol. 2013;31:210–6. doi: 10.1200/JCO.2011.41.0027.</cite> [<a href="https://doi.org/10.1200/JCO.2011.41.0027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3532393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23233716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Prevalence%20and%20type%20of%20BRCA%20mutations%20in%20Hispanics%20undergoing%20genetic%20cancer%20risk%20assessment%20in%20the%20southwestern%20United%20States:%20a%20report%20from%20the%20Clinical%20Cancer%20Genetics%20Community%20Research%20Network&amp;author=JN%20Weitzel&amp;author=J%20Clague&amp;author=A%20Martir-Negron&amp;author=R%20Ogaz&amp;author=J%20Herzog&amp;volume=31&amp;publication_year=2013&amp;pages=210-6&amp;pmid=23233716&amp;doi=10.1200/JCO.2011.41.0027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r46">
<span class="label">46.</span><cite>Zhang J, Pei R, Pang Z, Ouyang T, Li J, Wang T, et al.  Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat. 2012;132:421–8. doi: 10.1007/s10549-011-1596-x.</cite> [<a href="https://doi.org/10.1007/s10549-011-1596-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21614564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Prevalence%20and%20characterization%20of%20BRCA1%20and%20BRCA2%20germline%20mutations%20in%20Chinese%20women%20with%20familial%20breast%20cancer&amp;author=J%20Zhang&amp;author=R%20Pei&amp;author=Z%20Pang&amp;author=T%20Ouyang&amp;author=J%20Li&amp;volume=132&amp;publication_year=2012&amp;pages=421-8&amp;pmid=21614564&amp;doi=10.1007/s10549-011-1596-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r47">
<span class="label">47.</span><cite>Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al.  A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021;384:440–51. doi: 10.1056/NEJMoa2005936.</cite> [<a href="https://doi.org/10.1056/NEJMoa2005936" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8127622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20population-based%20study%20of%20genes%20previously%20implicated%20in%20breast%20cancer&amp;author=C%20Hu&amp;author=SN%20Hart&amp;author=R%20Gnanaolivu&amp;author=H%20Huang&amp;author=KY%20Lee&amp;volume=384&amp;publication_year=2021&amp;pages=440-51&amp;pmid=33471974&amp;doi=10.1056/NEJMoa2005936&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r48">
<span class="label">48.</span><cite>Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, et al.  Breast cancer risk genes – association analysis in more than 113,000 women. N Engl J Med. 2021;384:428–39. doi: 10.1056/NEJMoa1913948.</cite> [<a href="https://doi.org/10.1056/NEJMoa1913948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Breast%20cancer%20risk%20genes%20%E2%80%93%20association%20analysis%20in%20more%20than%20113,000%20women&amp;author=L%20Dorling&amp;author=S%20Carvalho&amp;author=J%20Allen&amp;author=A%20Gonzalez-Neira&amp;author=C%20Luccarini&amp;volume=384&amp;publication_year=2021&amp;pages=428-39&amp;pmid=33471991&amp;doi=10.1056/NEJMoa1913948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r49">
<span class="label">49.</span><cite>Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, et al.  Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast Cancer Res Treat. 2019;178:557–64. doi: 10.1007/s10549-019-05429-z.</cite> [<a href="https://doi.org/10.1007/s10549-019-05429-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31512090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Germline%20investigation%20in%20male%20breast%20cancer%20of%20DNA%20repair%20genes%20by%20next-generation%20sequencing&amp;author=R%20Scarpitta&amp;author=I%20Zanna&amp;author=P%20Aretini&amp;author=G%20Gambino&amp;author=C%20Scatena&amp;volume=178&amp;publication_year=2019&amp;pages=557-64&amp;pmid=31512090&amp;doi=10.1007/s10549-019-05429-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r50">
<span class="label">50.</span><cite>de Souza TA, Goncalves A, Sales L, Albuquerque BM, de Souza J, de Moura P, et al.  A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer. Breast Cancer Res Treat. 2018;172:637–46. doi: 10.1007/s10549-018-4938-0.</cite> [<a href="https://doi.org/10.1007/s10549-018-4938-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30159786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=A%20portrait%20of%20germline%20mutation%20in%20Brazilian%20at-risk%20for%20hereditary%20breast%20cancer&amp;author=TA%20de%20Souza&amp;author=A%20Goncalves&amp;author=L%20Sales&amp;author=BM%20Albuquerque&amp;author=J%20de%20Souza&amp;volume=172&amp;publication_year=2018&amp;pages=637-46&amp;pmid=30159786&amp;doi=10.1007/s10549-018-4938-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r51">
<span class="label">51.</span><cite>Jalkh N, Chouery E, Haidar Z, Khater C, Atallah D, Ali H, et al.  Next-generation sequencing in familial breast cancer patients from Lebanon. BMC Med Genomics. 2017;10:8. doi: 10.1186/s12920-017-0244-7.</cite> [<a href="https://doi.org/10.1186/s12920-017-0244-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5312584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28202063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med%20Genomics&amp;title=Next-generation%20sequencing%20in%20familial%20breast%20cancer%20patients%20from%20Lebanon&amp;author=N%20Jalkh&amp;author=E%20Chouery&amp;author=Z%20Haidar&amp;author=C%20Khater&amp;author=D%20Atallah&amp;volume=10&amp;publication_year=2017&amp;pages=8&amp;pmid=28202063&amp;doi=10.1186/s12920-017-0244-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r52">
<span class="label">52.</span><cite>Fewings E, Larionov A, Redman J, Goldgraben MA, Scarth J, Richardson S, et al.  Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study. Lancet Gastroenterol Hepatol. 2018;3:489–98. doi: 10.1016/S2468-1253(18)30079-7.</cite> [<a href="https://doi.org/10.1016/S2468-1253(18)30079-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5992580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29706558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Gastroenterol%20Hepatol&amp;title=Germline%20pathogenic%20variants%20in%20PALB2%20and%20other%20cancer-predisposing%20genes%20in%20families%20with%20hereditary%20diffuse%20gastric%20cancer%20without%20CDH1%20mutation:%20a%20whole-exome%20sequencing%20study&amp;author=E%20Fewings&amp;author=A%20Larionov&amp;author=J%20Redman&amp;author=MA%20Goldgraben&amp;author=J%20Scarth&amp;volume=3&amp;publication_year=2018&amp;pages=489-98&amp;pmid=29706558&amp;doi=10.1016/S2468-1253(18)30079-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r53">
<span class="label">53.</span><cite>Matakidou A, Eisen T, Fleischmann C, Bridle H, Houlston RS. Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition. Int J Cancer. 2006;119:964–7. doi: 10.1002/ijc.21931.</cite> [<a href="https://doi.org/10.1002/ijc.21931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16550608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Evaluation%20of%20xeroderma%20pigmentosum%20XPA,%20XPC,%20XPD,%20XPF,%20XPB,%20XPG%20and%20DDB2%20genes%20in%20familial%20early-onset%20lung%20cancer%20predisposition&amp;author=A%20Matakidou&amp;author=T%20Eisen&amp;author=C%20Fleischmann&amp;author=H%20Bridle&amp;author=RS%20Houlston&amp;volume=119&amp;publication_year=2006&amp;pages=964-7&amp;pmid=16550608&amp;doi=10.1002/ijc.21931&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r54">
<span class="label">54.</span><cite>Del VJ, Rofes P, Moreno-Cabrera JM, Lopez-Doriga A, Belhadj S, Vargas-Parra G, et al.  Exploring the role of mutations in fanconi anemia genes in hereditary cancer patients. Cancers (Basel) 2020:12. doi: 10.3390/cancers12040829.</cite> [<a href="https://doi.org/10.3390/cancers12040829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7226125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32235514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Exploring%20the%20role%20of%20mutations%20in%20fanconi%20anemia%20genes%20in%20hereditary%20cancer%20patients&amp;author=VJ%20Del&amp;author=P%20Rofes&amp;author=JM%20Moreno-Cabrera&amp;author=A%20Lopez-Doriga&amp;author=S%20Belhadj&amp;publication_year=2020&amp;pages=12&amp;pmid=32235514&amp;doi=10.3390/cancers12040829&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r55">
<span class="label">55.</span><cite>Ullah SA, Mahjabeen I, Kayani MA. Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associated with susceptibility to breast cancer. J BUON. 2015;20:985–93.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/26416047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20BUON&amp;title=Genetic%20polymorphisms%20in%20cell%20cycle%20regulatory%20genes%20CCND1%20and%20CDK4%20are%20associated%20with%20susceptibility%20to%20breast%20cancer&amp;author=SA%20Ullah&amp;author=I%20Mahjabeen&amp;author=MA%20Kayani&amp;volume=20&amp;publication_year=2015&amp;pages=985-93&amp;pmid=26416047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r56">
<span class="label">56.</span><cite>Lang GT, Shi JX, Hu X, Zhang CH, Shan L, Song CG, et al.  The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: screening of 2,991 patients and 1,043 controls by next-generation sequencing. Int J Cancer. 2017;141:129–42. doi: 10.1002/ijc.30692.</cite> [<a href="https://doi.org/10.1002/ijc.30692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28294317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=The%20spectrum%20of%20BRCA%20mutations%20and%20characteristics%20of%20BRCA-associated%20breast%20cancers%20in%20China:%20screening%20of%202,991%20patients%20and%201,043%20controls%20by%20next-generation%20sequencing&amp;author=GT%20Lang&amp;author=JX%20Shi&amp;author=X%20Hu&amp;author=CH%20Zhang&amp;author=L%20Shan&amp;volume=141&amp;publication_year=2017&amp;pages=129-42&amp;pmid=28294317&amp;doi=10.1002/ijc.30692&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r57">
<span class="label">57.</span><cite>Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. J Am Med Assoc. 2005;294:1925–33. doi: 10.1001/jama.294.15.1925.</cite> [<a href="https://doi.org/10.1001/jama.294.15.1925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16234499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Med%20Assoc&amp;title=Genetic%20testing%20in%20an%20ethnically%20diverse%20cohort%20of%20high-risk%20women:%20a%20comparative%20analysis%20of%20BRCA1%20and%20BRCA2%20mutations%20in%20American%20families%20of%20European%20and%20African%20ancestry&amp;author=R%20Nanda&amp;author=LP%20Schumm&amp;author=S%20Cummings&amp;author=JD%20Fackenthal&amp;author=L%20Sveen&amp;volume=294&amp;publication_year=2005&amp;pages=1925-33&amp;pmid=16234499&amp;doi=10.1001/jama.294.15.1925&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r58">
<span class="label">58.</span><cite>Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, et al.  BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer. 2009;115:2222–33. doi: 10.1002/cncr.24200.</cite> [<a href="https://doi.org/10.1002/cncr.24200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2771545/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19241424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=BRCA1%20and%20BRCA2%20mutations%20in%20women%20of%20different%20ethnicities%20undergoing%20testing%20for%20hereditary%20breast-ovarian%20cancer&amp;author=MJ%20Hall&amp;author=JE%20Reid&amp;author=LA%20Burbidge&amp;author=D%20Pruss&amp;author=AM%20Deffenbaugh&amp;volume=115&amp;publication_year=2009&amp;pages=2222-33&amp;pmid=19241424&amp;doi=10.1002/cncr.24200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r59">
<span class="label">59.</span><cite>Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329–33. doi: 10.1200/JCO.2006.09.1066.</cite> [<a href="https://doi.org/10.1200/JCO.2006.09.1066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2267287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17416853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Meta-analysis%20of%20BRCA1%20and%20BRCA2%20penetrance&amp;author=S%20Chen&amp;author=G%20Parmigiani&amp;volume=25&amp;publication_year=2007&amp;pages=1329-33&amp;pmid=17416853&amp;doi=10.1200/JCO.2006.09.1066&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r60">
<span class="label">60.</span><cite>Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117–30. doi: 10.1086/375033.</cite> [<a href="https://doi.org/10.1086/375033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1180265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12677558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Hum%20Genet&amp;title=Average%20risks%20of%20breast%20and%20ovarian%20cancer%20associated%20with%20BRCA1%20or%20BRCA2%20mutations%20detected%20in%20case%20Series%20unselected%20for%20family%20history:%20a%20combined%20analysis%20of%2022%20studies&amp;author=A%20Antoniou&amp;author=PD%20Pharoah&amp;author=S%20Narod&amp;author=HA%20Risch&amp;author=JE%20Eyfjord&amp;volume=72&amp;publication_year=2003&amp;pages=1117-30&amp;pmid=12677558&amp;doi=10.1086/375033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r61">
<span class="label">61.</span><cite>Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, et al.  Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst. 2006;98:116–22. doi: 10.1093/jnci/djj012.</cite> [<a href="https://doi.org/10.1093/jnci/djj012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16418514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Natl%20Cancer%20Inst&amp;title=Population-based%20study%20of%20changing%20breast%20cancer%20risk%20in%20Icelandic%20BRCA2%20mutation%20carriers,%201920-2000&amp;author=L%20Tryggvadottir&amp;author=H%20Sigvaldason&amp;author=GH%20Olafsdottir&amp;author=JG%20Jonasson&amp;author=T%20Jonsson&amp;volume=98&amp;publication_year=2006&amp;pages=116-22&amp;pmid=16418514&amp;doi=10.1093/jnci/djj012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r62">
<span class="label">62.</span><cite>Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al.  Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet. 2005;42:602–3. doi: 10.1136/jmg.2004.024133.</cite> [<a href="https://doi.org/10.1136/jmg.2004.024133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1736090/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15994883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Breast%20and%20ovarian%20cancer%20risks%20to%20carriers%20of%20the%20BRCA1%205382insC%20and%20185delAG%20and%20BRCA2%206174delT%20mutations:%20a%20combined%20analysis%20of%2022%20population%20based%20studies&amp;author=AC%20Antoniou&amp;author=PD%20Pharoah&amp;author=S%20Narod&amp;author=HA%20Risch&amp;author=JE%20Eyfjord&amp;volume=42&amp;publication_year=2005&amp;pages=602-3&amp;pmid=15994883&amp;doi=10.1136/jmg.2004.024133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r63">
<span class="label">63.</span><cite>Park B, Dowty JG, Ahn C, Win AK, Kim SW, Lee MH, et al.  Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2. Breast Cancer Res Treat. 2015;152:659–65. doi: 10.1007/s10549-015-3495-z.</cite> [<a href="https://doi.org/10.1007/s10549-015-3495-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26195121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Breast%20cancer%20risk%20for%20Korean%20women%20with%20germline%20mutations%20in%20BRCA1%20and%20BRCA2&amp;author=B%20Park&amp;author=JG%20Dowty&amp;author=C%20Ahn&amp;author=AK%20Win&amp;author=SW%20Kim&amp;volume=152&amp;publication_year=2015&amp;pages=659-65&amp;pmid=26195121&amp;doi=10.1007/s10549-015-3495-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r64">
<span class="label">64.</span><cite>Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, et al.  Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev. 1999;8:741–7.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10498392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol%20Biomarkers%20Prev&amp;title=Population-based%20estimate%20of%20the%20average%20age-specific%20cumulative%20risk%20of%20breast%20cancer%20for%20a%20defined%20set%20of%20protein-truncating%20mutations%20in%20BRCA1%20and%20BRCA2.%20Australian%20Breast%20Cancer%20Family%20Study&amp;author=JL%20Hopper&amp;author=MC%20Southey&amp;author=GS%20Dite&amp;author=DJ%20Jolley&amp;author=GG%20Giles&amp;volume=8&amp;publication_year=1999&amp;pages=741-7&amp;pmid=10498392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r65">
<span class="label">65.</span><cite>Yao L, Sun J, Zhang J, He Y, Ouyang T, Li J, et al.  Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Res Treat. 2016;156:441–5. doi: 10.1007/s10549-016-3766-3.</cite> [<a href="https://doi.org/10.1007/s10549-016-3766-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27033093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Breast%20cancer%20risk%20in%20Chinese%20women%20with%20BRCA1%20or%20BRCA2%20mutations&amp;author=L%20Yao&amp;author=J%20Sun&amp;author=J%20Zhang&amp;author=Y%20He&amp;author=T%20Ouyang&amp;volume=156&amp;publication_year=2016&amp;pages=441-5&amp;pmid=27033093&amp;doi=10.1007/s10549-016-3766-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r66">
<span class="label">66.</span><cite>Lin PH, Kuo WH, Huang AC, Lu YS, Lin CH, Kuo SH, et al.  Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget. 2016;7:8310–20. doi: 10.18632/oncotarget.7027.</cite> [<a href="https://doi.org/10.18632/oncotarget.7027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4884994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26824983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Multiple%20gene%20sequencing%20for%20risk%20assessment%20in%20patients%20with%20early-onset%20or%20familial%20breast%20cancer&amp;author=PH%20Lin&amp;author=WH%20Kuo&amp;author=AC%20Huang&amp;author=YS%20Lu&amp;author=CH%20Lin&amp;volume=7&amp;publication_year=2016&amp;pages=8310-20&amp;pmid=26824983&amp;doi=10.18632/oncotarget.7027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r67">
<span class="label">67.</span><cite>Kraus C, Hoyer J, Vasileiou G, Wunderle M, Lux MP, Fasching PA, et al.  Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2. Int J Cancer. 2017;140:95–102. doi: 10.1002/ijc.30428.</cite> [<a href="https://doi.org/10.1002/ijc.30428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27616075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Gene%20panel%20sequencing%20in%20familial%20breast/ovarian%20cancer%20patients%20identifies%20multiple%20novel%20mutations%20also%20in%20genes%20others%20than%20BRCA1/2&amp;author=C%20Kraus&amp;author=J%20Hoyer&amp;author=G%20Vasileiou&amp;author=M%20Wunderle&amp;author=MP%20Lux&amp;volume=140&amp;publication_year=2017&amp;pages=95-102&amp;pmid=27616075&amp;doi=10.1002/ijc.30428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r68">
<span class="label">68.</span><cite>Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–51. doi: 10.1056/NEJM198501173120303.</cite> [<a href="https://doi.org/10.1056/NEJM198501173120303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3965932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Risk%20factors%20for%20breast%20cancer%20in%20women%20with%20proliferative%20breast%20disease&amp;author=WD%20Dupont&amp;author=DL%20Page&amp;volume=312&amp;publication_year=1985&amp;pages=146-51&amp;pmid=3965932&amp;doi=10.1056/NEJM198501173120303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r69">
<span class="label">69.</span><cite>Lalloo F, Evans DG. Familial breast cancer. Clin Genet. 2012;82:105–14. doi: 10.1111/j.1399-0004.2012.01859.x.</cite> [<a href="https://doi.org/10.1111/j.1399-0004.2012.01859.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22356477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=Familial%20breast%20cancer&amp;author=F%20Lalloo&amp;author=DG%20Evans&amp;volume=82&amp;publication_year=2012&amp;pages=105-14&amp;pmid=22356477&amp;doi=10.1111/j.1399-0004.2012.01859.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r70">
<span class="label">70.</span><cite>Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, et al.  Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol. 2016;13:581–8. doi: 10.1038/nrclinonc.2016.90.</cite> [<a href="https://doi.org/10.1038/nrclinonc.2016.90" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5513673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27296296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Counselling%20framework%20for%20moderate-penetrance%20cancer-susceptibility%20mutations&amp;author=N%20Tung&amp;author=SM%20Domchek&amp;author=Z%20Stadler&amp;author=KL%20Nathanson&amp;author=F%20Couch&amp;volume=13&amp;publication_year=2016&amp;pages=581-8&amp;pmid=27296296&amp;doi=10.1038/nrclinonc.2016.90&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r71">
<span class="label">71.</span><cite>Powell SN, Bindra RS. Targeting the DNA damage response for cancer therapy. DNA Repair (Amst) 2009;8:1153–65. doi: 10.1016/j.dnarep.2009.04.011.</cite> [<a href="https://doi.org/10.1016/j.dnarep.2009.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19501553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=DNA%20Repair%20(Amst)&amp;title=Targeting%20the%20DNA%20damage%20response%20for%20cancer%20therapy&amp;author=SN%20Powell&amp;author=RS%20Bindra&amp;volume=8&amp;publication_year=2009&amp;pages=1153-65&amp;pmid=19501553&amp;doi=10.1016/j.dnarep.2009.04.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r72">
<span class="label">72.</span><cite>Ranjha L, Howard SM, Cejka P. Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes. Chromosoma. 2018;127:187–214. doi: 10.1007/s00412-017-0658-1.</cite> [<a href="https://doi.org/10.1007/s00412-017-0658-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29327130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chromosoma&amp;title=Main%20steps%20in%20DNA%20double-strand%20break%20repair:%20an%20introduction%20to%20homologous%20recombination%20and%20related%20processes&amp;author=L%20Ranjha&amp;author=SM%20Howard&amp;author=P%20Cejka&amp;volume=127&amp;publication_year=2018&amp;pages=187-214&amp;pmid=29327130&amp;doi=10.1007/s00412-017-0658-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r73">
<span class="label">73.</span><cite>Mahaney BL, Meek K, Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J. 2009;417:639–50. doi: 10.1042/BJ20080413.</cite> [<a href="https://doi.org/10.1042/BJ20080413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2975036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19133841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20J&amp;title=Repair%20of%20ionizing%20radiation-induced%20DNA%20double-strand%20breaks%20by%20non-homologous%20end-joining&amp;author=BL%20Mahaney&amp;author=K%20Meek&amp;author=SP%20Lees-Miller&amp;volume=417&amp;publication_year=2009&amp;pages=639-50&amp;pmid=19133841&amp;doi=10.1042/BJ20080413&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r74">
<span class="label">74.</span><cite>Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95:866–71. doi: 10.1111/j.1349-7006.2004.tb02195.x.</cite> [<a href="https://doi.org/10.1111/j.1349-7006.2004.tb02195.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11159131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15546503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci&amp;title=Role%20of%20BRCA1%20and%20BRCA2%20as%20regulators%20of%20DNA%20repair,%20transcription,%20and%20cell%20cycle%20in%20response%20to%20DNA%20damage&amp;author=K%20Yoshida&amp;author=Y%20Miki&amp;volume=95&amp;publication_year=2004&amp;pages=866-71&amp;pmid=15546503&amp;doi=10.1111/j.1349-7006.2004.tb02195.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r75">
<span class="label">75.</span><cite>Ford BN, Ruttan CC, Kyle VL, Brackley ME, Glickman BW. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis. 2000;21:1977–81. doi: 10.1093/carcin/21.11.1977.</cite> [<a href="https://doi.org/10.1093/carcin/21.11.1977" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11062157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Identification%20of%20single%20nucleotide%20polymorphisms%20in%20human%20DNA%20repair%20genes&amp;author=BN%20Ford&amp;author=CC%20Ruttan&amp;author=VL%20Kyle&amp;author=ME%20Brackley&amp;author=BW%20Glickman&amp;volume=21&amp;publication_year=2000&amp;pages=1977-81&amp;pmid=11062157&amp;doi=10.1093/carcin/21.11.1977&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r76">
<span class="label">76.</span><cite>Lotsari JE, Gylling A, Abdel-Rahman WM, Nieminen TT, Aittomaki K, Friman M, et al.  Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases. Breast Cancer Res. 2012;14:R90. doi: 10.1186/bcr3205.</cite> [<a href="https://doi.org/10.1186/bcr3205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3446353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22691310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=Breast%20carcinoma%20and%20Lynch%20syndrome:%20molecular%20analysis%20of%20tumors%20arising%20in%20mutation%20carriers,%20non-carriers,%20and%20sporadic%20cases&amp;author=JE%20Lotsari&amp;author=A%20Gylling&amp;author=WM%20Abdel-Rahman&amp;author=TT%20Nieminen&amp;author=K%20Aittomaki&amp;volume=14&amp;publication_year=2012&amp;pages=R90&amp;pmid=22691310&amp;doi=10.1186/bcr3205&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r77">
<span class="label">77.</span><cite>Williams SA, Wilson JB, Clark AP, Mitson-Salazar A, Tomashevski A, Ananth S, et al.  Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet. 2011;20:4395–410. doi: 10.1093/hmg/ddr366.</cite> [<a href="https://doi.org/10.1093/hmg/ddr366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3196888/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21865299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mol%20Genet&amp;title=Functional%20and%20physical%20interaction%20between%20the%20mismatch%20repair%20and%20FA-BRCA%20pathways&amp;author=SA%20Williams&amp;author=JB%20Wilson&amp;author=AP%20Clark&amp;author=A%20Mitson-Salazar&amp;author=A%20Tomashevski&amp;volume=20&amp;publication_year=2011&amp;pages=4395-410&amp;pmid=21865299&amp;doi=10.1093/hmg/ddr366&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r78">
<span class="label">78.</span><cite>Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (Review) Oncol Rep. 2013;30:1019–29. doi: 10.3892/or.2013.2541.</cite> [<a href="https://doi.org/10.3892/or.2013.2541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23779253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Rep&amp;title=Hereditary%20breast%20and%20ovarian%20cancer%20susceptibility%20genes%20(Review)&amp;author=H%20Kobayashi&amp;author=S%20Ohno&amp;author=Y%20Sasaki&amp;author=M%20Matsuura&amp;volume=30&amp;publication_year=2013&amp;pages=1019-29&amp;pmid=23779253&amp;doi=10.3892/or.2013.2541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r79">
<span class="label">79.</span><cite>Lan Y, Zhao E, Luo S, Xiao Y, Li X, Cheng S. Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer. Breast Cancer Res Treat. 2019;175:91–104. doi: 10.1007/s10549-019-05153-8.</cite> [<a href="https://doi.org/10.1007/s10549-019-05153-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30739230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=Revealing%20clonality%20and%20subclonality%20of%20driver%20genes%20for%20clinical%20survival%20benefits%20in%20breast%20cancer&amp;author=Y%20Lan&amp;author=E%20Zhao&amp;author=S%20Luo&amp;author=Y%20Xiao&amp;author=X%20Li&amp;volume=175&amp;publication_year=2019&amp;pages=91-104&amp;pmid=30739230&amp;doi=10.1007/s10549-019-05153-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r80">
<span class="label">80.</span><cite>Ng C, Bidard FC, Piscuoglio S, Geyer FC, Lim RS, de Bruijn I, et al.  Genetic heterogeneity in therapy-naive synchronous primary breast cancers and their metastases. Clin Cancer Res. 2017;23:4402–15. doi: 10.1158/1078-0432.CCR-16-3115.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-3115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5768571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28351929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Genetic%20heterogeneity%20in%20therapy-naive%20synchronous%20primary%20breast%20cancers%20and%20their%20metastases&amp;author=C%20Ng&amp;author=FC%20Bidard&amp;author=S%20Piscuoglio&amp;author=FC%20Geyer&amp;author=RS%20Lim&amp;volume=23&amp;publication_year=2017&amp;pages=4402-15&amp;pmid=28351929&amp;doi=10.1158/1078-0432.CCR-16-3115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9257317/bin/cbm-19-850-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (82.5KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cancer Biology &amp; Medicine are provided here courtesy of <strong>Chinese Anti-Cancer Association</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.20892/j.issn.2095-3941.2021.0011"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cbm-19-850.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9257317/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9257317/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9257317%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9257317/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9257317/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9257317/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34570441/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9257317/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34570441/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9257317/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9257317/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="e6OV8l0LCAk4ZXCUJ6Vg8codlajUHRLTQge8UdtjTiOoa37VZ5jQFkhTs2I7KCgo">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
